Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,8.083023854609374e-36,18.01303317535545,1455.5124750480416,"['RPL5', 'RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS17', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPL22', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL28', 'UBA52', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPS3', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPS20', 'FAU', 'RPS21', 'RPS24', 'RPS23']",4.372915905343671e-33,0,0,69
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,7.698427006231984e-33,14.978832398994781,1107.59915741513,"['COX7B', 'NDUFA12', 'COX4I1', 'COX6A1', 'COX7C', 'ATP5IF1', 'UQCRFS1', 'NDUFC2', 'SDHC', 'NDUFC1', 'SDHD', 'SDHB', 'COX6B1', 'COX7A2L', 'SCO1', 'NDUFS6', 'NDUFS5', 'NDUFS1', 'UQCRC2', 'SLC25A5', 'SLC25A6', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'COX15', 'NDUFB5', 'NDUFB4', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'COX11', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'ATP5F1C', 'ATP5F1E', 'UQCRQ', 'NDUFAB1', 'ATP5PO']",2.082424505185752e-30,0,0,67
3,Oxidative phosphorylation WP623,1.6125706487043173e-17,12.289374222562435,475.18238153434925,"['NDUFB8', 'NDUFB7', 'NDUFA11', 'NDUFB10', 'NDUFB6', 'NDUFB5', 'NDUFB4', 'ATP5MC2', 'NDUFB2', 'ATP5MC3', 'NDUFB1', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'NDUFV3', 'NDUFV1', 'ATP5MG', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA8', 'NDUFA7', 'NDUFA6', 'ATP5PD', 'NDUFA5', 'ATP5PB', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFC2', 'NDUFC1', 'ATP5F1E', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'ATP5PO', 'NDUFS1']",2.9080024031634524e-15,0,0,37
4,Mitochondrial complex I assembly model OXPHOS system WP4324,6.623810633576928e-17,11.953225883590799,445.29681996915264,"['NDUFA13', 'NDUFB8', 'NDUFB7', 'DMAC1', 'NDUFB10', 'NDUFB6', 'NDUFA12', 'DMAC2', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'ECSIT', 'TMEM186', 'FOXRED1', 'NDUFV3', 'NDUFV1', 'NDUFA8', 'NDUFA7', 'COA1', 'NDUFA6', 'NDUFA5', 'NDUFA3', 'ACAD9', 'NDUFA2', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAB1', 'NDUFS1', 'TMEM126B', 'NDUFAF1']",8.958703881912796e-15,0,0,36
5,Nonalcoholic fatty liver disease WP4396,7.000300273449476e-13,3.7324333445831925,104.46204990810857,"['NDUFA13', 'COX7B', 'NDUFA11', 'NDUFA12', 'COX4I1', 'PRKAG1', 'COX6A1', 'COX7C', 'UQCRFS1', 'RAC1', 'NDUFC2', 'SDHC', 'TRAF2', 'NDUFC1', 'SDHD', 'SDHB', 'COX6B1', 'COX7A2L', 'NDUFS6', 'DDIT3', 'NDUFS5', 'NDUFS1', 'UQCRC2', 'ATF4', 'NDUFB8', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB6', 'NDUFB11', 'NDUFB5', 'NDUFB4', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'UQCRH', 'CDC42', 'NDUFV3', 'NDUFV1', 'NDUFA8', 'XBP1', 'NDUFA7', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA3', 'NDUFA2', 'NDUFA1', 'COX6C', 'COX7B2', 'EIF2S1', 'UQCRQ', 'NDUFAB1', 'CYCS', 'BAX']",7.574324895872334e-11,0,0,60
6,Mitochondrial CIV Assembly WP4922,3.3025442996657617e-10,10.181872709096968,222.28206939065706,"['COA3', 'COX7B', 'COX16', 'PET100', 'COX15', 'NDUFA4', 'TACO1', 'COX4I1', 'COX17', 'COX7A2', 'COX6A1', 'HIGD1A', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'TMEM177', 'PNKD', 'COX11', 'COX14', 'SMIM20']",2.9777941101986285e-08,0,0,22
7,Cellular Proteostasis WP4918,3.236870726855003e-05,inf,inf,"['VBP1', 'PFDN1', 'PFDN2', 'PFDN4', 'PFDN5', 'PFDN6']",0.002501638661755081,0,0,6
8,Base Excision Repair WP4752,0.0002674119858829668,4.037097042206713,33.212067263699545,"['FEN1', 'PARP1', 'MPG', 'APEX2', 'LIG3', 'HMGB1', 'POLE4', 'POLD4', 'NEIL2', 'NTHL1', 'APEX1', 'POLD2', 'POLE3', 'POLL']",0.017503170233309148,0,0,14
9,Proteasome Degradation WP183,0.0003179176440063438,2.7465079207831624,22.119600800144465,"['UBE2B', 'H2AFZ', 'PSMD13', 'UBE2D2', 'PSMA7', 'PSMD8', 'PSMA5', 'PSMB6', 'PSMB7', 'PSMA3', 'PSMC5', 'PSMD7', 'PSMB5', 'PSMD4', 'PSMA1', 'PSMB2', 'PSMA2', 'PSMB3', 'PSME3', 'PSMC1', 'PSME1', 'PSME2']",0.017503170233309148,0,0,22
10,Mitochondrial complex III assembly WP4921,0.0003235336457173595,6.914233576642336,55.564215339017025,"['UQCRB', 'UQCC2', 'UQCRQ', 'LYRM7', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRC2', 'UQCRH']",0.017503170233309148,0,0,9
11,Mitochondrial CII Assembly WP4920,0.0006508504324220491,13.818694066953928,101.39094624047993,"['SDHAF2', 'SDHAF1', 'SDHAF4', 'SDHC', 'SDHD', 'SDHB']",0.03201000763093896,0,0,6
12,Translation Factors WP107,0.0008079688710683188,2.7408559420772303,19.51759960391602,"['EIF5B', 'EIF2B2', 'EIF2AK1', 'EIF2S2', 'EIF2S1', 'EIF1', 'EEF1B2', 'EEF1A1', 'EIF5', 'EIF2S3', 'EIF6', 'EIF3I', 'EIF3J', 'EIF4H', 'ETF1', 'EIF3F', 'EIF2B1', 'EIF3D', 'EIF4B']",0.03642592993733004,0,0,19
13,Nucleotide Excision Repair WP4753,0.0009321547376662048,2.9055962149774524,20.275284469364145,"['RFC3', 'RFC2', 'CETN2', 'RPA2', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'POLE4', 'DDB1', 'POLD4', 'CDK7', 'ERCC3', 'POLD2', 'ERCC2', 'POLE3', 'ERCC8']",0.03879197792903206,0,0,17
14,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.0011134063747906696,5.184928666224287,35.25923195426572,"['EIF5', 'EIF2S3', 'EIF3I', 'EIF3J', 'EIF3F', 'EIF2S2', 'EIF2S1', 'EIF3D', 'EIF1']",0.043025203482982305,0,0,9
15,Pyrimidine metabolism WP4022,0.0016647927662405931,2.144513561180228,13.72071491495324,"['POLD4', 'ZNRD1', 'POLR2D', 'TWISTNB', 'POLD2', 'POLR2E', 'TK2', 'POLR2G', 'POLR2I', 'POLR2J', 'POLR2K', 'POLR2L', 'DUT', 'RRM2', 'POLR3GL', 'NME2', 'NME1', 'DCTD', 'POLE4', 'POLR3A', 'POLR3D', 'POLE3', 'POLR3F', 'POLR1E', 'DCTPP1', 'POLR3K']",0.0600435257690774,0,0,26
16,Eukaryotic Transcription Initiation WP405,0.004456627644455966,2.5620567375886525,13.869342974207276,"['TAF12', 'TAF13', 'GTF2H3', 'CDK7', 'ERCC3', 'POLR3D', 'ERCC2', 'POLR2E', 'POLR2F', 'POLR1E', 'POLR2G', 'POLR2I', 'POLR2J', 'POLR3K', 'POLR2K']",0.15068972222816737,0,0,15
17,DNA Repair Pathways Full Network WP4946,0.005042290572011173,1.7726880298669985,9.377333229451358,"['FEN1', 'WDR48', 'MPG', 'CETN2', 'HMGB1', 'POLD4', 'NTHL1', 'POLD2', 'POLL', 'XRCC6', 'RFC3', 'XRCC4', 'PARP1', 'CENPX', 'XRCC5', 'RFC2', 'RPA2', 'APEX2', 'LIG3', 'RAD23A', 'GTF2H3', 'GTF2H5', 'RBX1', 'FANCF', 'DDB1', 'POLE4', 'CDK7', 'NEIL2', 'ERCC3', 'APEX1', 'ERCC2', 'POLE3', 'ERCC8']",0.16046348232106145,0,0,33
18,Purine metabolism WP4792,0.006569409337608717,5.5262843884653625,27.771410205594403,"['DGUOK', 'ADSL', 'ATIC', 'HPRT1', 'ITPA', 'APRT']",0.19744724731368424,0,0,6
19,Glycosylation and related congenital defects WP4521,0.007822897050922005,3.0720212412877532,14.901454437088033,"['DPM2', 'ALG8', 'DPM3', 'ALG6', 'MPI', 'SRD5A3', 'ALG14', 'ALG3', 'MAGT1', 'ALG11']",0.21160936522744023,0,0,10
20,Photodynamic therapy-induced unfolded protein response WP3613,0.007822897050922005,3.0720212412877532,14.901454437088033,"['NARS', 'DNAJC3', 'XBP1', 'WARS', 'DDIT3', 'DNAJB11', 'CALR', 'PDIA6', 'HSP90B1', 'ATF4']",0.21160936522744023,0,0,10
21,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.011400586213552343,2.2308253260123543,9.980914404210473,"['XBP1', 'PPP1R11', 'PPP1R10', 'EIF2AK1', 'PPP1R3A', 'EIF2S1', 'PPP1R2', 'MAP1LC3A', 'PPP1R1A', 'PPP1R7', 'PPP1R3E', 'DDIT3', 'PPP1R8', 'PPP1R12C', 'ATF4']",0.2937008162634199,0,0,15
22,Canonical and non-canonical Notch signaling WP3845,0.01818869125847851,2.763901791639018,11.07483075979826,"['DLL4', 'HEY1', 'RRAS', 'MFAP1', 'NOTCH4', 'PSEN2', 'DLL1', 'DLL3', 'DLK2']",0.4472764532198579,0,0,9
23,Ciliary landscape WP4352,0.02602533946931715,1.4058945644864185,5.129665875621468,"['UBE2D2', 'MCM9', 'MYL6B', 'PSMD8', 'PSMD7', 'ARHGDIA', 'NEFL', 'RAC1', 'SNAP29', 'RAB8A', 'BBS4', 'RAB2A', 'EIF5B', 'NUDC', 'DYNLT1', 'EIPR1', 'DYNLT3', 'DYNLL1', 'DYNLL2', 'AFG3L2', 'TIPRL', 'MCM4', 'PAFAH1B1', 'ECHS1', 'PSMD13', 'CAMK2A', 'COPS7B', 'COPS7A', 'EXOSC7', 'RMND5B', 'PGRMC2', 'EXOSC4', 'SNRPB2', 'DCAF11', 'NDUFA5', 'COX6C', 'LSM4', 'AIMP1', 'COPS4', 'IFT20', 'COPS3', 'IFT22', 'RAB14', 'MFAP1', 'IFT27', 'DYNLRB2', 'COPS8', 'CALM2', 'CNOT9']",0.6121612457782859,0,0,49
24,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.029365055725396664,2.9303110682421027,10.337990617694194,"['MDH2', 'IDH2', 'IDH3B', 'SDHC', 'SDHD', 'SDHB', 'DLD']",0.6396598651817884,0,0,7
25,Pathogenic Escherichia coli infection WP2272,0.029559143492688927,1.9202958776595744,6.762057236782,"['ARPC5L', 'LY96', 'ARPC4', 'ARPC5', 'YWHAZ', 'RHOA', 'ACTG1', 'TUBB8', 'CDC42', 'TUBA1A', 'TUBB2A', 'YWHAQ', 'ARPC2', 'ARPC3', 'ARHGEF2']",0.6396598651817884,0,0,15
26,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.032986375438413824,1.76539809537296,6.022939245823927,"['HSPA9', 'HSPA8', 'PSMD13', 'SIAH2', 'HSPA6', 'UBE2G2', 'UBE2J2', 'HSPA14', 'PSMD8', 'TUBB8', 'PSMC5', 'TUBA1A', 'PSMD7', 'TUBB2A', 'PSMD4', 'PSMC1', 'HSPA1B', 'HSPA1A']",0.6863703504685338,0,0,18
27,mRNA Processing WP411,0.034818937253165386,1.5055023923444977,5.054865598189373,"['SF3B5', 'DHX8', 'RNMT', 'SRP54', 'CSTF2T', 'SNU13', 'SNRPD1', 'CLP1', 'CSTF1', 'SNRPB2', 'SNRPD3', 'TXNL4A', 'HNRNPA1', 'SF3A1', 'SNRPN', 'PRMT2', 'NCBP2', 'CPSF3', 'LSM2', 'PRPF4', 'LSM7', 'PHF5A', 'SNRPG', 'SNRPE', 'SNRPA1', 'SNRPF', 'DNAJC8', 'RBMX', 'SNRPA', 'SNRPB', 'SRSF9']",0.6976683353319435,0,0,31
28,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.03870775292725239,4.602517389864193,14.966076514177079,"['CUL2', 'ELOB', 'ELOC', 'RBX1']",0.7370725781227899,0,0,4
29,Nucleotide metabolism WP404,0.039510360010278946,2.6859250663129974,8.678740561116497,"['PRPS2', 'ADSL', 'RRM2', 'NME2', 'HPRT1', 'OAZ1', 'SRM']",0.7370725781227899,0,0,7
30,Somitogenesis in the context of spondylocostal dysostosis WP4785,0.06001566188249705,3.6817489234845975,10.357310951178109,"['MESP2', 'RIPPLY2', 'DLL1', 'DLL3']",0.9999950664293745,0,0,4
31,Glycolysis and Gluconeogenesis WP534,0.06377219646456112,1.8763464659879003,5.164527268570374,"['TPI1', 'GOT1', 'MPC1', 'MDH2', 'MPC2', 'PGK1', 'ALDOA', 'DLD', 'PFKM', 'GCK', 'FBP2']",0.9999950664293745,0,0,11
32,Cori Cycle WP1946,0.06611756765786637,2.876698144466534,7.814034986407378,"['G6PD', 'TPI1', 'PGK1', 'TALDO1', 'ALDOA']",0.9999950664293745,0,0,5
33,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.08105232817871733,1.841885164288085,4.628031740512355,"['STAR', 'CREB3L4', 'CREB3L1', 'CAMK2A', 'CREB3L2', 'CALM3', 'REN', 'CALM2', 'CREB5', 'ATF4']",0.9999950664293745,0,0,10
34,Non-homologous end joining WP438,0.08627229504591453,3.0679032792315337,7.517120079711946,"['XRCC6', 'XRCC4', 'XRCC5', 'POLL']",0.9999950664293745,0,0,4
35,Zinc homeostasis WP3529,0.08742759936618114,1.8835283826989202,4.590053688200647,"['SLC30A9', 'SLC30A3', 'SLC39A9', 'SLC30A4', 'SLC39A10', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'SLC39A3']",0.9999950664293745,0,0,9
36,16p11.2 proximal deletion syndrome WP4949,0.08748031939997937,1.5355954757152361,3.741234880369246,"['CCT3', 'IGBP1', 'INO80E', 'PRRT2', 'DOC2A', 'TRAF2', 'KIF22', 'SEZ6L2', 'PAGR1', 'PPP2CB', 'HIRIP3', 'ASPHD1', 'TRAF6', 'KCTD13', 'ALDOA', 'CDIPT', 'CCT4']",0.9999950664293745,0,0,17
37,7q11.23 copy number variation syndrome WP4932,0.08783706980908733,1.43231981981982,3.483790905879586,"['BECN1', 'RFC2', 'ATP5PB', 'ATP5MC2', 'VPS37C', 'ATP5MC3', 'DDX21', 'ATP5F1E', 'ATP5MC1', 'ATP5F1A', 'ATP5F1B', 'MYBBP1A', 'DNAJC30', 'CFL1', 'EIF4H', 'ATP5PO', 'METTL27', 'SQSTM1', 'DLD', 'STX1A', 'VAMP2', 'ATF4', 'ATPAF1']",0.9999950664293745,0,0,23
38,Intraflagellar transport proteins binding to dynein WP4532,0.09412781675875265,1.938378284018504,4.580584955376704,"['IFT22', 'DYNC1LI2', 'DYNLT1', 'DYNLT3', 'IFT27', 'DYNLRB2', 'DYNLL1', 'DYNLL2']",0.9999950664293745,0,0,8
39,DNA Mismatch Repair WP531,0.10101062635668735,2.0138635610079576,4.61684173581097,"['POLE4', 'POLD4', 'RFC3', 'RFC2', 'POLD2', 'POLE3', 'RPA2']",0.9999950664293745,0,0,7
40,Dual hijack model of Vif in HIV infection WP3300,0.11329435664923926,3.450745033112583,7.514914935551433,"['ELOB', 'ELOC', 'RBX1']",0.9999950664293745,0,0,3
41,Pentose Phosphate Metabolism WP134,0.11329435664923926,3.450745033112583,7.514914935551433,"['G6PD', 'TALDO1', 'PGLS']",0.9999950664293745,0,0,3
42,Computational Model of Aerobic Glycolysis WP4629,0.11708588315576064,2.6294421047650594,5.639752507274495,"['TPI1', 'PGK1', 'ALDOA', 'PFKM']",0.9999950664293745,0,0,4
43,Exercise-induced Circadian Regulation WP410,0.12054196362835608,1.5786686909901788,3.3400798716480335,"['HIST1H2BN', 'DNAJA1', 'IDI1', 'DAZAP2', 'PPP2CB', 'HSPA8', 'SUMO1', 'CBX3', 'STBD1', 'CRY2', 'AZIN1', 'EIF4G2']",0.9999950664293745,0,0,12
44,Amyotrophic lateral sclerosis (ALS) WP2447,0.12054335658667219,1.7263188453881884,3.6524518208125674,"['CASP9', 'CCS', 'TOMM40', 'CAT', 'NEFL', 'BAX', 'RAC1', 'RAB5A', 'SOD1']",0.9999950664293745,0,0,9
45,Purine metabolism and related disorders WP4224,0.13179098452993382,1.972394526255978,3.9971325805593794,"['DGUOK', 'ADSL', 'ATIC', 'HPRT1', 'ITPA', 'APRT']",0.9999950664293745,0,0,6
46,Regulation of Microtubule Cytoskeleton WP2038,0.13205573171317225,1.5825966965471447,3.2040164454427376,"['CDC42', 'PAK1', 'DPYSL2', 'STMN1', 'RHO', 'CDK1', 'TESK2', 'RAC1', 'MAPT', 'PRKACA', 'PHLDB2']",0.9999950664293745,0,0,11
47,Cytosolic DNA-sensing pathway WP4655,0.13594976010286258,1.5347060777150447,3.062459741228392,"['POLR3A', 'POLR3GL', 'POLR3D', 'POLR2E', 'POLR3F', 'POLR2F', 'ISG15', 'IKBKG', 'POLR3K', 'POLR2K', 'POLR2L', 'NFKBIB']",0.9999950664293745,0,0,12
48,NAD+ metabolism WP3644,0.1421788680838877,2.091692270618712,4.080200063969764,"['NT5E', 'PARP1', 'SIRT5', 'SIRT6', 'NADK']",0.9999950664293745,0,0,5
49,NOTCH1 regulation of endothelial cell calcification WP3413,0.1421788680838877,2.091692270618712,4.080200063969764,"['DLL4', 'CALU', 'ALPL', 'DLL1', 'DLL3']",0.9999950664293745,0,0,5
50,NO metabolism in cystic fibrosis WP4947,0.15189080046346753,2.300596223915204,4.335688538624037,"['PRMT6', 'PRMT5', 'PRMT8', 'PRMT2']",0.9999950664293745,0,0,4
51,RalA downstream regulated genes WP2290,0.15189080046346753,2.300596223915204,4.335688538624037,"['CDC42', 'RAC2', 'RAC1', 'HRAS']",0.9999950664293745,0,0,4
52,Estrogen metabolism WP697,0.15804633847888877,2.7603973509933777,5.092566000277512,"['SULT1A1', 'STS', 'ARSE']",0.9999950664293745,0,0,3
53,Interleukin-1 Induced Activation of NF-kappa-B WP3656,0.15804633847888877,2.7603973509933777,5.092566000277512,"['TRAF6', 'UBE2V1', 'SQSTM1']",0.9999950664293745,0,0,3
54,SARS-CoV-2 mitochondrial interactions WP5038,0.16871934132727417,1.6955186374424125,3.017207031256278,"['TOMM70', 'CTSL', 'TRAF6', 'ACAD9', 'PHB', 'NDUFAF1', 'ECSIT']",0.9999950664293745,0,0,7
55,Glutathione metabolism WP100,0.19001224545249654,2.044827205476427,3.3957765683371504,"['G6PD', 'GPX4', 'GPX3', 'GSS']",0.9999950664293745,0,0,4
56,Major receptors targeted by epinephrine and norepinephrine WP4589,0.19001224545249654,2.044827205476427,3.3957765683371504,"['ADRA1D', 'ADCY1', 'ADCY8', 'ADCY7']",0.9999950664293745,0,0,4
57,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.20692803023622422,1.7696385787837081,2.787860703072646,"['RAB5C', 'MRAS', 'RRAS', 'HRAS', 'RAB5A']",0.9999950664293745,0,0,5
58,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.20706168663755004,2.3001655629139073,3.6221593304702804,"['E2F1', 'CHI3L1', 'BAX']",0.9999950664293745,0,0,3
59,Serotonin Transporter Activity WP1455,0.20706168663755004,2.3001655629139073,3.6221593304702804,"['PPP2CB', 'IL1R1', 'STX1A']",0.9999950664293745,0,0,3
60,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.21964367623990005,3.0665342601787486,4.648095315738541,"['UROC1', 'FTCD']",0.9999950664293745,0,0,2
61,Composition of Lipid Particles WP3601,0.21964367623990005,3.0665342601787486,4.648095315738541,"['APOA1', 'LPL']",0.9999950664293745,0,0,2
62,Mitochondrial fatty acid synthesis pathway WP4317,0.21964367623990005,3.0665342601787486,4.648095315738541,"['MECR', 'MCAT']",0.9999950664293745,0,0,2
63,SARS-CoV-2 and angiotensin-converting enzyme 2 receptor: molecular mechanisms WP4883,0.21964367623990005,3.0665342601787486,4.648095315738541,"['MAS1', 'REN']",0.9999950664293745,0,0,2
64,Cysteine and methionine catabolism WP4504,0.23072187069980415,1.8402119907254058,2.698748756323677,"['BHMT', 'GOT1', 'GSS', 'SUOX']",0.9999950664293745,0,0,4
65,Fatty acid transporters WP5061,0.23072187069980415,1.8402119907254058,2.698748756323677,"['FABP3', 'FABP5', 'FABP6', 'FABP7']",0.9999950664293745,0,0,4
66,p38 MAPK Signaling Pathway WP400,0.25228709387303094,1.415792830718204,1.9498123002448646,"['CDC42', 'STAT1', 'DDIT3', 'TRAF2', 'RAC1', 'HRAS', 'MEF2D', 'HMGN1']",0.9999950664293745,0,0,8
67,Dopamine metabolism WP2436,0.2588285699750801,1.9714285714285715,2.664561818881034,"['PPP2CB', 'PRKACA', 'SOD1']",0.9999950664293745,0,0,3
68,Gene regulatory network modelling somitogenesis  WP2854,0.2588285699750801,1.9714285714285715,2.664561818881034,"['MESP2', 'RIPPLY2', 'DLL1']",0.9999950664293745,0,0,3
69,Methionine De Novo and Salvage Pathway WP3580,0.27919591366553814,1.5334658714380385,1.9564594651932987,"['BHMT', 'ODC1', 'TXN', 'ENOPH1', 'SRM']",0.9999950664293745,0,0,5
70,Cell migration and invasion through p75NTR WP4561,0.2811858258271204,1.452819984997296,1.8432501396173089,"['ARF1', 'PAK1', 'EFNB3', 'EFNA2', 'RAC1', 'RHOA']",0.9999950664293745,0,0,6
71,Striated Muscle Contraction Pathway WP383,0.2811858258271204,1.452819984997296,1.8432501396173089,"['ACTA1', 'TPM4', 'TPM3', 'TNNC2', 'TPM1', 'ACTG1']",0.9999950664293745,0,0,6
72,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.29227495791496083,2.2997351870241642,2.828812915161137,"['GGCT', 'GSS']",0.9999950664293745,0,0,2
73,Metastatic brain tumor WP2249,0.29227495791496083,2.2997351870241642,2.828812915161137,"['CDC42', 'E2F3']",0.9999950664293745,0,0,2
74,Peroxiredoxin 2 induced ovarian failure WP4873,0.29227495791496083,2.2997351870241642,2.828812915161137,"['STAR', 'BAX']",0.9999950664293745,0,0,2
75,"Phase I biotransformations, non P450 WP136",0.29227495791496083,2.2997351870241642,2.828812915161137,"['ESD', 'CES2']",0.9999950664293745,0,0,2
76,NRF2 pathway WP2884,0.298701086979454,1.1638419377448896,1.4062840802427437,"['CBR1', 'ABCC4', 'G6PD', 'HSP90AA1', 'HSP90AB1', 'GPX3', 'MGST3', 'TGFA', 'SLC39A10', 'TXN', 'CES4A', 'DNAJB1', 'GSTA4', 'SLC39A9', 'FTH1', 'SLC39A7', 'SLC39A1', 'SQSTM1', 'SLC39A4', 'CES2', 'SLC39A3', 'HSPA1A']",0.9999950664293745,0,0,22
77,VEGFA-VEGFR2 Signaling Pathway WP3888,0.3016325599060429,1.0771047479836078,1.2909592549114768,"['YWHAE', 'RPL5', 'CCDC124', 'ARPC5L', 'SRP54', 'HMGB1', 'RPL10A', 'RPL7', 'ACTG1', 'RND1', 'TUBB8', 'PSMD4', 'RPL18A', 'TMSB4X', 'CFL1', 'RACK1', 'RPLP2', 'ELOC', 'RAC1', 'ATP6V1E1', 'TMSB10', 'ACP1', 'HRAS', 'HSP90AA1', 'SSR4', 'TPM3', 'PRKCD', 'SSR3', 'SARS', 'RPL13A', 'PDIA6', 'RHOA', 'FSCN1', 'RPL27', 'RPL26', 'ALDOA', 'SLC25A11', 'ATF4', 'NAPA', 'LRRC59', 'SET', 'NOTCH4', 'CRIP2', 'TXN', 'NDRG1', 'CAMKK2', 'CDC42', 'DLL4', 'STIP1', 'PAK1', 'DHX36', 'AP2S1', 'PGK1', 'ZC3H15', 'TXNDC5', 'DECR1', 'SDF2L1', 'STAT1', 'SIAH2', 'IDH2', 'DNAJA1', 'TFCP2', 'GIPC1', 'CALU', 'NOX4', 'CYCS', 'HYOU1', 'TPP1', 'P4HB', 'EIF3F', 'CALR', 'GRSF1', 'RAB5A', 'EIF3D', 'EIF4G2', 'HSPA1A']",0.9999950664293745,0,0,76
78,Myometrial relaxation and contraction pathways WP289,0.3039189418420463,1.140144045271371,1.3579050041511027,"['YWHAE', 'YWHAB', 'CAMK2A', 'ADCY1', 'ADCY8', 'ADCY7', 'ACTG1', 'RGS4', 'GNG3', 'RGS3', 'YWHAQ', 'PDE4B', 'PRKACA', 'YWHAH', 'PRKCG', 'IGFBP2', 'PRKCD', 'YWHAZ', 'ACTA1', 'PRKAR1A', 'GNB1', 'CRH', 'CALM3', 'GNB5', 'ATF5', 'CALM2', 'ATF4']",0.9999950664293745,0,0,27
79,Metabolic reprogramming in colon cancer WP4290,0.30399325183718684,1.2939926177836762,1.5408214194173784,"['G6PD', 'MDH2', 'IDH2', 'PGK1', 'PYCR1', 'TALDO1', 'PYCR2', 'PDHB', 'SDHB']",0.9999950664293745,0,0,9
80,Farnesoid X receptor pathway WP2879,0.3119820713501248,1.7248758278145695,2.009151847919644,"['ABCB4', 'ABCB11', 'SLC27A5']",0.9999950664293745,0,0,3
81,Sulfation Biotransformation Reaction WP692,0.3119820713501248,1.7248758278145695,2.009151847919644,"['SULT1A1', 'G6PD', 'SULT4A1']",0.9999950664293745,0,0,3
82,Notch Signaling Pathway Netpath WP61,0.3138082946940254,1.2269677847891065,1.4220225417693064,"['PSENEN', 'DLL4', 'NUMBL', 'NCSTN', 'HEY1', 'NOTCH4', 'PSEN2', 'CIR1', 'MAPT', 'DLL1', 'SKP1', 'DLL3']",0.9999950664293745,0,0,12
83,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.3169841235835429,1.5332891685988739,1.761601429838711,"['RPH3A', 'GCC2', 'SYTL2', 'EXPH5']",0.9999950664293745,0,0,4
84,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.3170348176078194,1.4375207090788602,1.6513428242645798,"['G6PD', 'PARP1', 'GOT1', 'MDH2', 'SIRT5']",0.9999950664293745,0,0,5
85,Arylamine metabolism WP694,0.3253812653133265,4.598941098610192,5.163496347198311,['SULT1A1'],0.9999950664293745,0,0,1
86,SCFA and skeletal muscle substrate metabolism WP4030,0.3253812653133265,4.598941098610192,5.163496347198311,['PYY'],0.9999950664293745,0,0,1
87,Gastric Cancer Network 2 WP2363,0.34923987066460166,1.314266773994981,1.3826037629182162,"['OTUD5', 'RFC3', 'DSCC1', 'S100A6', 'BRIX1', 'COL9A3']",0.9999950664293745,0,0,6
88,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.34923987066460166,1.314266773994981,1.3826037629182162,"['RAB3A', 'RAB4B', 'HSPB8', 'MPZ', 'NEFL', 'NDRG1']",0.9999950664293745,0,0,6
89,Synaptic Vesicle Pathway WP2267,0.35047198765827026,1.2106311247750974,1.2693158593474307,"['NAPA', 'RAB3A', 'STXBP1', 'AP2S1', 'CLTA', 'PARK7', 'SYP', 'AP2M1', 'VAMP2', 'STX1A']",0.9999950664293745,0,0,10
90,Unfolded protein response WP4925,0.35543027661377224,1.3528632128795852,1.3994371208201317,"['XBP1', 'DDIT3', 'RTCB', 'EIF2S1', 'ATF4']",0.9999950664293745,0,0,5
91,"Cerebral organic acidurias, including diseases WP4519",0.36386718197026496,1.8396557431314133,1.8598300751232804,"['MDH2', 'IDH2']",0.9999950664293745,0,0,2
92,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.36386718197026496,1.8396557431314133,1.8598300751232804,"['HEY1', 'HIF1AN']",0.9999950664293745,0,0,2
93,MAPK and NFkB signaling pathways inhibited by Yersinia YopJ WP3849,0.3653458158290687,1.533112582781457,1.5437078215987698,"['RRAS', 'TRAF6', 'IKBKG']",0.9999950664293745,0,0,3
94,Osteoclast Signaling WP12,0.3653458158290687,1.533112582781457,1.5437078215987698,"['AIMP2', 'ATP6V1G1', 'IFNAR1']",0.9999950664293745,0,0,3
95,Fas ligand pathway and stress induction of heat shock proteins WP314,0.3659788521871065,1.2266666666666666,1.2330204665425613,"['CASP9', 'ACTA1', 'PAK1', 'PARP1', 'ARHGDIB', 'CYCS', 'SPTAN1', 'ACTG1']",0.9999950664293745,0,0,8
96,Ferroptosis WP4313,0.3659788521871065,1.2266666666666666,1.2330204665425613,"['MAP1LC3B', 'MAP1LC3A', 'GPX4', 'FTH1', 'GSS', 'LPCAT3', 'VDAC2', 'SLC3A2']",0.9999950664293745,0,0,8
97,Non-small cell lung cancer WP4255,0.3666056079447905,1.1501329345297442,1.1541223391275846,"['ALK', 'PRKCG', 'GADD45A', 'TGFA', 'CASP9', 'RXRB', 'RASSF1', 'ERBB2', 'E2F1', 'CYCS', 'BAX', 'E2F3', 'JAK3', 'HRAS']",0.9999950664293745,0,0,14
98,Selenium Micronutrient Network WP15,0.3666056079447905,1.1501329345297442,1.1541223391275846,"['GPX4', 'GPX3', 'APOA1', 'TXN', 'SELENOH', 'SOD1', 'SELENOM', 'PRDX5', 'PRDX4', 'FLAD1', 'CAT', 'SELENOW', 'SEPHS2', 'MSRB1']",0.9999950664293745,0,0,14
99,G Protein Signaling Pathways WP35,0.3835172332298753,1.1172559642619524,1.0707454056539827,"['PRKCG', 'PRKCD', 'AKAP5', 'ADCY1', 'ADCY8', 'ADCY7', 'RHOA', 'GNG10', 'GNG3', 'RRAS', 'PRKAR1A', 'GNB1', 'PDE4B', 'GNB5', 'PRKACA', 'HRAS', 'CALM2']",0.9999950664293745,0,0,17
100,Aryl Hydrocarbon Receptor Pathway WP2873,0.3838324103695582,1.25443697833489,1.201185191524542,"['HSP90AA1', 'PTGES3', 'CDC37', 'MYOF', 'BAX', 'CAP2']",0.9999950664293745,0,0,6
101,Retinoblastoma gene in cancer WP2446,0.3917894783909344,1.1152160111255556,1.0449915596766497,"['PLK4', 'RFC3', 'RRM2', 'PRMT2', 'H2AFZ', 'SUV39H1', 'HMGB2', 'RPA2', 'HMGB1', 'RBBP4', 'KIF4A', 'STMN1', 'E2F1', 'CDK1', 'MCM4', 'E2F3']",0.9999950664293745,0,0,16
102,G1 to S cell cycle control WP45,0.4067412917362683,1.1264818115888002,1.0133581903195248,"['CDKN2D', 'CDK7', 'CCND2', 'ORC6', 'CREB3L4', 'GADD45A', 'CREB3L1', 'E2F1', 'CDK1', 'MCM4', 'RPA2', 'E2F3']",0.9999950664293745,0,0,12
103,Common Pathways Underlying Drug Addiction WP2636,0.42475239829301153,1.1498341625207298,0.9845442047400316,"['PRKCG', 'PPP1R1A', 'CAMK2A', 'ADCY1', 'ADCY8', 'PRKACA', 'CALM2', 'ACTG1']",0.9999950664293745,0,0,8
104,DNA Replication WP466,0.42475239829301153,1.1498341625207298,0.9845442047400316,"['POLD4', 'RFC3', 'ORC6', 'RFC2', 'POLD2', 'RPA2', 'MCM4', 'UBA52']",0.9999950664293745,0,0,8
105,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.43230686902634663,1.2102821666492274,1.0149663439956265,"['RBBP4', 'H3F3B', 'CBX3', 'SUV39H1', 'E2F1']",0.9999950664293745,0,0,5
106,Macrophage markers WP4146,0.4324741038766884,1.5329361138695796,1.2849573766812263,"['RAC2', 'CD68']",0.9999950664293745,0,0,2
107,Vitamin D Metabolism WP1531,0.4324741038766884,1.5329361138695796,1.2849573766812263,"['RXRB', 'CYP24A1']",0.9999950664293745,0,0,2
108,One-carbon metabolism and related pathways WP3940,0.4404947065724454,1.1187252282142792,0.917194542223123,"['DMGDH', 'BHMT', 'AHCYL1', 'GPX4', 'GPX3', 'BHMT2', 'GSS', 'GPX7', 'SOD1']",0.9999950664293745,0,0,9
109,3q29 copy number variation syndrome WP4906,0.44176238970257603,1.0998253363358161,0.8985387361762504,"['TM4SF19', 'DYNLT1', 'NCBP2', 'DYNLT3', 'RNF8', 'PIGZ', 'WDR53', 'DYNLRB2', 'MELTF', 'DYNLL1', 'DYNLL2']",0.9999950664293745,0,0,11
110,GABA metabolism (aka GHB) WP4157,0.44591137869140024,2.2993050959629384,1.8569993842847015,['AKR7A2'],0.9999950664293745,0,0,1
111,Ebstein-Barr virus LMP1 signaling WP262,0.44867019754648013,1.2263663464723418,0.9828923868698025,"['HSP90AA1', 'TRAF6', 'TRAF1', 'IKBKG']",0.9999950664293745,0,0,4
112,Joubert Syndrome WP4656,0.45323473650023105,1.0731472249916916,0.8492298040740012,"['PARP1', 'CETN2', 'ARL3', 'RHOA', 'TMEM231', 'TMEM17', 'TCTN3', 'TMEM138', 'TCTN1', 'B9D1', 'CEP41', 'RAB8A', 'BBS4', 'ATF4']",0.9999950664293745,0,0,14
113,Calcium Regulation in the Cardiac Cell WP536,0.45617356027412326,1.0453180908484445,0.820451277731169,"['YWHAE', 'YWHAB', 'CAMK2A', 'ADRA1D', 'ADCY1', 'ADCY8', 'ADCY7', 'RGS4', 'GNG3', 'RGS3', 'YWHAQ', 'ANXA6', 'PRKACA', 'YWHAH', 'PRKCG', 'PRKCD', 'ATP2B3', 'ATP2B2', 'YWHAZ', 'PRKAR1A', 'GNB1', 'CALM3', 'CALR', 'GNB5', 'CALM2']",0.9999950664293745,0,0,25
114,Genes related to primary cilium development (based on CRISPR) WP4536,0.4603418568227367,1.052829159514222,0.816770015485906,"['TTC23', 'MKKS', 'DYNLT1', 'ARL3', 'TUBD1', 'DYNLL1', 'TXNDC15', 'TMEM231', 'IFT20', 'TMEM17', 'KIF3B', 'TCTN3', 'BBS12', 'TMEM107', 'TCTN1', 'CEP83', 'IFT27', 'B9D1', 'BBS4']",0.9999950664293745,0,0,19
115,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.466360763255116,1.076347093893928,0.8210330148982985,"['ACTR2', 'ACTA1', 'PAK1', 'FZD4', 'TMSB4X', 'ERBB2', 'NEFL', 'TGFA', 'RHOA', 'PFN2', 'SOD1']",0.9999950664293745,0,0,11
116,Pancreatic adenocarcinoma pathway WP4263,0.47263166691729436,1.0511853294693334,0.7877991882870129,"['STAT1', 'GADD45A', 'PRKCD', 'PEBP1', 'TGFA', 'RHOA', 'CASP9', 'CDC42', 'PAK1', 'ERBB2', 'RAC2', 'E2F1', 'BAX', 'E2F3', 'RAC1', 'IKBKG']",0.9999950664293745,0,0,16
117,PPAR signaling pathway WP3942,0.47997804072772793,1.06947413919527,0.7850099796543965,"['RXRB', 'FABP3', 'CPT2', 'FABP5', 'FABP6', 'FABP7', 'OLR1', 'APOA1', 'LPL', 'SLC27A5']",0.9999950664293745,0,0,10
118,Notch Signaling WP268,0.483024387149261,1.0820407765096087,0.7873882353143652,"['DLL4', 'NUMBL', 'NCSTN', 'NOTCH4', 'PSEN2', 'DTX4', 'DLL1', 'DLL3']",0.9999950664293745,0,0,8
119,Urea cycle and metabolism of amino groups WP497,0.49103874891969074,1.149635640940709,0.8176579274127632,"['ODC1', 'PYCR1', 'PYCR3', 'SRM']",0.9999950664293745,0,0,4
120,ATR Signaling WP3875,0.4968776190458967,1.313850664396841,0.9189222935913121,"['RAD1', 'ATRIP']",0.9999950664293745,0,0,2
121,"Degradation pathway of sphingolipids, including diseases WP4153",0.4968776190458967,1.313850664396841,0.9189222935913121,"['NEU3', 'GM2A']",0.9999950664293745,0,0,2
122,IL-10 Anti-inflammatory Signaling Pathway  WP4495,0.4968776190458967,1.313850664396841,0.9189222935913121,"['STAT1', 'BLVRA']",0.9999950664293745,0,0,2
123,Role of Osx and miRNAs in tooth development WP3971,0.4968776190458967,1.313850664396841,0.9189222935913121,"['NOTCH4', 'ALPL']",0.9999950664293745,0,0,2
124,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.4968776190458967,1.313850664396841,0.9189222935913121,"['CCND2', 'MEF2D']",0.9999950664293745,0,0,2
125,Supression of HMGB1 mediated inflammation by THBD WP4479,0.4968776190458967,1.313850664396841,0.9189222935913121,"['HMGB1', 'IKBKG']",0.9999950664293745,0,0,2
126,Thiamine metabolic pathways WP4297,0.4968776190458967,1.313850664396841,0.9189222935913121,"['BCKDHA', 'SLC25A19']",0.9999950664293745,0,0,2
127,Oxidative Damage WP3941,0.5001115786481376,1.0729774535809018,0.7434918807192104,"['CDC42', 'CASP9', 'GADD45A', 'TRAF6', 'CYCS', 'TRAF2', 'TRAF1']",0.9999950664293745,0,0,7
128,16p11.2 distal deletion syndrome WP4950,0.507030274622318,1.094859414938938,0.7436116142832168,"['CD81', 'TRAF2', 'TRAF1', 'RAB5A', 'SH2B1']",0.9999950664293745,0,0,5
129,Cholesterol Biosynthesis Pathway WP197,0.5179379423377277,1.1495860927152317,0.7563125137477654,"['IDI1', 'NSDHL', 'PMVK']",0.9999950664293745,0,0,3
130,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.5179379423377277,1.1495860927152317,0.7563125137477654,"['CD63', 'CD81', 'SOD1']",0.9999950664293745,0,0,3
131,TP53 network WP1742,0.5179379423377277,1.1495860927152317,0.7563125137477654,"['SUMO1', 'GADD45A', 'BAX']",0.9999950664293745,0,0,3
132,Fatty acid beta-oxidation WP143,0.5197425427281592,1.0611407154330588,0.6944335110945461,"['ECHS1', 'TPI1', 'CPT2', 'LPL', 'DLD', 'DECR1']",0.9999950664293745,0,0,6
133,Pregnane X receptor pathway WP2876,0.5319808283481651,1.0819320772363268,0.6828590797574754,"['ABCC4', 'HSP90AA1', 'PSMC5', 'DNAJC7']",0.9999950664293745,0,0,4
134,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.5396465206747239,1.021779988944168,0.6302757340700806,"['CFL1', 'BANF1', 'ADCY1', 'SYNE4', 'ADCY8', 'ADCY7', 'HRAS', 'RHOA']",0.9999950664293745,0,0,8
135,Oxidative Stress WP408,0.5428917106014982,1.0450177721549492,0.6383443062773954,"['GPX3', 'CAT', 'NOX4', 'TXN2', 'SOD1']",0.9999950664293745,0,0,5
136,Type II interferon signaling (IFNG) WP619,0.5428917106014982,1.0450177721549492,0.6383443062773954,"['STAT1', 'IFNGR2', 'PRKCD', 'IFI6', 'ISG15']",0.9999950664293745,0,0,5
137,Aflatoxin B1 metabolism WP699,0.544912907879921,1.5327597617471873,0.9305833599053767,['AKR7A2'],0.9999950664293745,0,0,1
138,Gastric acid production WP2596,0.544912907879921,1.5327597617471873,0.9305833599053767,['GRP'],0.9999950664293745,0,0,1
139,Hypothetical Craniofacial Development Pathway WP3655,0.544912907879921,1.5327597617471873,0.9305833599053767,['RHOA'],0.9999950664293745,0,0,1
140,MED and Pseudoachondroplasia genes WP4789,0.544912907879921,1.5327597617471873,0.9305833599053767,['COL9A3'],0.9999950664293745,0,0,1
141,Secretion of Hydrochloric Acid in Parietal Cells WP2597,0.544912907879921,1.5327597617471873,0.9305833599053767,['CCKBR'],0.9999950664293745,0,0,1
142,Steroid Biosynthesis WP496,0.544912907879921,1.5327597617471873,0.9305833599053767,['HSD17B1'],0.9999950664293745,0,0,1
143,Vitamin B6-dependent and responsive disorders WP4228,0.544912907879921,1.5327597617471873,0.9305833599053767,['PIGV'],0.9999950664293745,0,0,1
144,CAMKK2  Pathway WP4874,0.5520062865998459,1.021765550767871,0.6071288438107413,"['FIS1', 'MAP1LC3A', 'RAC1', 'SQSTM1', 'CALM2', 'CAMKK2']",0.9999950664293745,0,0,6
145,Melatonin metabolism and effects WP3298,0.5520062865998459,1.021765550767871,0.6071288438107413,"['SULT1A1', 'AANAT', 'TRAF6', 'CAMK2A', 'CRY2', 'CALM2']",0.9999950664293745,0,0,6
146,Type 2 papillary renal cell carcinoma WP4241,0.5520062865998459,1.021765550767871,0.6071288438107413,"['CUL2', 'TGFA', 'ELOB', 'ELOC', 'VHL', 'RBX1']",0.9999950664293745,0,0,6
147,ACE Inhibitor Pathway WP554,0.5563898436271884,1.1495365772922874,0.6739572854692134,"['MAS1', 'REN']",0.9999950664293745,0,0,2
148,Cytokines and Inflammatory Response WP530,0.5563898436271884,1.1495365772922874,0.6739572854692134,"['IL11', 'HLA-DRB1']",0.9999950664293745,0,0,2
149,Cell cycle WP179,0.5570449334986889,0.9886887306242145,0.578491042036138,"['YWHAE', 'CDKN2D', 'ANAPC13', 'GADD45A', 'YWHAB', 'YWHAZ', 'RBX1', 'ANAPC11', 'CDK7', 'CCND2', 'ORC6', 'YWHAQ', 'CDK1', 'E2F1', 'MCM4', 'E2F3', 'E2F5', 'BUB1', 'SKP1', 'YWHAH']",0.9999950664293745,0,0,20
150,PDGF Pathway WP2526,0.5599418082487928,1.0057713030503979,0.5832693224935629,"['CDC42', 'PAK1', 'STAT1', 'RAC1', 'HRAS', 'RHOA', 'VAV1']",0.9999950664293745,0,0,7
151,Overview of interferons-mediated signaling pathway WP4558,0.5643118713979656,1.061079979623026,0.6070950182664389,"['STAT1', 'IFNGR2', 'IFNAR1']",0.9999950664293745,0,0,3
152,Small cell lung cancer WP4658,0.5710915423366778,0.9807515796474892,0.5494226868400321,"['LAMA1', 'GADD45A', 'TRAF2', 'TRAF1', 'CKS1B', 'CASP9', 'RXRB', 'TRAF6', 'TRAF5', 'E2F1', 'CYCS', 'BAX', 'E2F3', 'IKBKG', 'SKP1', 'NFKBIB']",0.9999950664293745,0,0,16
153,Fatty Acid Biosynthesis WP357,0.5712142599245557,1.0217511317213206,0.5721713393173746,"['MECR', 'ECHS1', 'ECH1', 'DECR1']",0.9999950664293745,0,0,4
154,Nanoparticle triggered autophagic cell death WP2509,0.5712142599245557,1.0217511317213206,0.5721713393173746,"['BECN1', 'MAP1LC3A', 'CHAF1A', 'ATG9B']",0.9999950664293745,0,0,4
155,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.5734931837219207,0.9851881694947389,0.5477737134426003,"['OTUD5', 'TKFC', 'TRAF6', 'DHX58', 'PIN1', 'TRAF2', 'ISG15', 'IKBKG', 'NFKBIB']",0.9999950664293745,0,0,9
156,RANKL/RANK signaling pathway WP2018,0.5734931837219207,0.9851881694947389,0.5477737134426003,"['CDC42', 'STAT1', 'TRAF6', 'TRAF5', 'TRAF2', 'RAC1', 'IKBKG', 'TRAF1', 'SQSTM1']",0.9999950664293745,0,0,9
157,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.5774697980870641,0.9995101852652203,0.548830178791007,"['CRTAP', 'CREB3L1', 'SERPINH1', 'P4HB', 'PPIB']",0.9999950664293745,0,0,5
158,Parkinson's disease pathway WP2371,0.5832387175509147,0.9852028978644822,0.5311807258382008,"['CASP9', 'SYT11', 'CYCS', 'PARK7', 'UBE2G2', 'UBE2J2']",0.9999950664293745,0,0,6
159,Histone Modifications WP2369,0.5936757775490571,0.9678624421750894,0.5046647100070032,"['SET', 'H3F3B', 'KMT5C', 'SUV39H1', 'EHMT2', 'PRDM2', 'HIST1H4C', 'HIST1H4E']",0.9999950664293745,0,0,8
160,AGE/RAGE pathway WP2324,0.6030098293261497,0.9577248589445735,0.48443809451161557,"['CASP9', 'CDC42', 'STAT1', 'PRKCD', 'ALPL', 'CYCS', 'RAC1', 'DDOST', 'RHOA', 'SOD1']",0.9999950664293745,0,0,10
161,PPAR-alpha pathway WP2878,0.6078432173908603,0.9852175969725638,0.4904790500626959,"['CPT2', 'CDK1', 'APOA1']",0.9999950664293745,0,0,3
162,Biogenic Amine Synthesis WP550,0.6107026404304251,1.0217367317665231,0.5038644782394252,"['AANAT', 'PAH']",0.9999950664293745,0,0,2
163,Glycolysis in senescence WP5049,0.6107026404304251,1.0217367317665231,0.5038644782394252,"['G6PD', 'PGK1']",0.9999950664293745,0,0,2
164,Mevalonate arm of cholesterol biosynthesis pathway WP4190,0.6107026404304251,1.0217367317665231,0.5038644782394252,"['IDI1', 'PMVK']",0.9999950664293745,0,0,2
165,Modulators of TCR signaling and T cell activation WP5072,0.6226953854620726,0.9402711588345297,0.445404405353739,"['ITK', 'FIBP', 'NDUFB10', 'TRAF6', 'ELOB', 'IKBKG', 'RNF7', 'MEF2D', 'VAV1']",0.9999950664293745,0,0,9
166,Benzene metabolism WP3891,0.6262301468317921,1.1494870946393116,0.5380028692091589,['DHDH'],0.9999950664293745,0,0,1
167,EV release from cardiac cells and their functional effects WP3297,0.6262301468317921,1.1494870946393116,0.5380028692091589,['MYB'],0.9999950664293745,0,0,1
168,Hfe effect on hepcidin production WP3924,0.6262301468317921,1.1494870946393116,0.5380028692091589,['HJV'],0.9999950664293745,0,0,1
169,Robo4 and VEGF Signaling Pathways Crosstalk WP3943,0.6262301468317921,1.1494870946393116,0.5380028692091589,['RAC1'],0.9999950664293745,0,0,1
170,The alternative pathway of fetal androgen synthesis WP4524,0.6262301468317921,1.1494870946393116,0.5380028692091589,['STAR'],0.9999950664293745,0,0,1
171,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.642173437784653,0.9194168323392975,0.40720682758159554,"['CASP9', 'NDUFA13', 'HSP90AA1', 'RAC1', 'IKBKG']",0.9999950664293745,0,0,5
172,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.642173437784653,0.9194168323392975,0.40720682758159554,"['YWHAQ', 'LPL', 'RAC1', 'NDRG1', 'RHOA']",0.9999950664293745,0,0,5
173,DNA IR-double strand breaks and cellular response via ATM WP3959,0.6461389518871602,0.9193098871930989,0.4015000459743515,"['CASP9', 'MDC1', 'RASSF1', 'PARP1', 'TRAF6', 'RNF8', 'E2F1', 'NABP2', 'BAX']",0.9999950664293745,0,0,9
174,Apoptosis Modulation by HSP70 WP384,0.6483651748560992,0.9194701986754967,0.3984075403722806,"['CASP9', 'CYCS', 'HSPA1A']",0.9999950664293745,0,0,3
175,Nanomaterial induced apoptosis WP2507,0.6483651748560992,0.9194701986754967,0.3984075403722806,"['CASP9', 'BAX', 'CYCS']",0.9999950664293745,0,0,3
176,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.6483651748560992,0.9194701986754967,0.3984075403722806,"['SUV39H1', 'CDC37', 'ECSIT']",0.9999950664293745,0,0,3
177,DNA IR-damage and cellular response via ATR WP4016,0.65473947386986,0.9192026578073089,0.3892987538354128,"['MDC1', 'FEN1', 'PARP1', 'XRCC5', 'RECQL', 'RPA2', 'E2F1', 'CDK1', 'RAD1', 'IKBKG', 'CLSPN', 'EEF1E1', 'ATRIP']",0.9999950664293745,0,0,13
178,Androgen receptor signaling pathway WP138,0.6570596355710586,0.9191758059155866,0.38603591005446597,"['DSTN', 'PARK7', 'RNF4', 'RHOA', 'RHOB', 'CDC42', 'SUMO1', 'BAG1', 'RACK1', 'KAT7', 'RAC1', 'CALR', 'FKBP4', 'RAN']",0.9999950664293745,0,0,14
179,B Cell Receptor Signaling Pathway WP23,0.6594001439214916,0.9191489361702128,0.38275634765098243,"['PTPN18', 'CD81', 'PRKCD', 'CAMK2A', 'ILF2', 'VAV1', 'CDC42', 'INPP5D', 'RAC2', 'E2F3', 'RAC1', 'IKBKG', 'PIK3AP1', 'HRAS', 'MEF2D']",0.9999950664293745,0,0,15
180,Disorders of Folate Metabolism and Transport WP4259,0.6597739609565285,0.919496855345912,0.38238011041743586,"['ATIC', 'FTCD']",0.9999950664293745,0,0,2
181,Drug Induction of Bile Acid Pathway WP2289,0.6597739609565285,0.919496855345912,0.38238011041743586,"['ABCC4', 'ABCB11']",0.9999950664293745,0,0,2
182,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.6597739609565285,0.919496855345912,0.38238011041743586,"['LPL', 'APOA1']",0.9999950664293745,0,0,2
183,ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337,0.6597739609565285,0.919496855345912,0.38238011041743586,"['IL11', 'JAK3']",0.9999950664293745,0,0,2
184,Copper homeostasis WP3286,0.6683391256065232,0.896849087893864,0.36139391492410355,"['BACE1', 'CCS', 'SCO1', 'COX17', 'COX11', 'MAPT', 'ATOX1', 'SOD1']",0.9999950664293745,0,0,8
185,G13 Signaling Pathway WP524,0.6696221690907205,0.8896682241491761,0.35679401469511074,"['CDC42', 'ARHGDIB', 'CFL1', 'RAC1', 'CALM2', 'RHOA']",0.9999950664293745,0,0,6
186,Oxidation by Cytochrome P450 WP43,0.6696221690907205,0.8896682241491761,0.35679401469511074,"['CYB5R1', 'CYP26B1', 'CYP4X1', 'CYB5R3', 'CYP24A1', 'CYP20A1']",0.9999950664293745,0,0,6
187,Fluoropyrimidine Activity WP1601,0.6720914105955202,0.8839909262374471,0.35126344775496215,"['ABCC4', 'RRM2', 'ERCC2', 'GGH', 'CES2']",0.9999950664293745,0,0,5
188,Amino Acid metabolism WP3925,0.6735140298387012,0.905209906372697,0.3577810039093778,"['WARS', 'GOT1', 'MDH2', 'MARS2', 'GSS', 'ODC1', 'PYCR1', 'FTCD', 'SRM', 'BHMT', 'RARS', 'IARS', 'DLD']",0.9999950664293745,0,0,13
189,Cannabinoid receptor signaling WP3869,0.6768538888180042,0.8755974068991624,0.34174553736276236,"['PRKAR1A', 'ADCY1', 'PRKACA', 'ADCY7']",0.9999950664293745,0,0,4
190,MTHFR deficiency WP4288,0.6768538888180042,0.8755974068991624,0.34174553736276236,"['CASP9', 'BHMT', 'EHMT2', 'CYCS']",0.9999950664293745,0,0,4
191,RAS and bradykinin pathways in COVID-19 WP4969,0.6858079472399238,0.8619412251655629,0.3250877275629405,"['CYP24A1', 'REN', 'RHOA']",0.9999950664293745,0,0,3
192,ATM Signaling Network in Development and Disease  WP3878,0.6929201148536661,0.8695426195426196,0.31898350220840227,"['MDC1', 'G6PD', 'RNF8', 'CDK1', 'IKBKG', 'BUB1', 'HMGN1']",0.9999950664293745,0,0,7
193,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.6929201148536661,0.8695426195426196,0.31898350220840227,"['STAT1', 'TRAF6', 'DHX58', 'TRAF5', 'TRAF2', 'RAE1', 'IFNAR1']",0.9999950664293745,0,0,7
194,miRNA Biogenesis WP2338,0.6930211141757805,0.9195234943745864,0.3371844953316764,['RAN'],0.9999950664293745,0,0,1
195,Molybdenum cofactor (Moco) biosynthesis WP4507,0.6930211141757805,0.9195234943745864,0.3371844953316764,['SUOX'],0.9999950664293745,0,0,1
196,SARS-CoV-2 and COVID-19 Pathway WP4846,0.6930211141757805,0.9195234943745864,0.3371844953316764,['CTSL'],0.9999950664293745,0,0,1
197,Vitamin A and carotenoid metabolism WP716,0.6957263776685078,0.8618039443155452,0.3126614639621076,"['RXRB', 'SULT1A1', 'SDR16C5', 'CYP26B1', 'RBP4', 'LPL']",0.9999950664293745,0,0,6
198,Neural Crest Cell Migration during Development WP4564,0.7003041373684707,0.8511891613283263,0.3032281003853542,"['ARF1', 'PAK1', 'RAC1', 'RHOA', 'NGEF']",0.9999950664293745,0,0,5
199,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.7021111559056121,0.9016792543288897,0.3188910822108168,"['YWHAE', 'NFYA', 'YWHAB', 'MBD1', 'SSTR1', 'ASCL1', 'YWHAZ', 'GCK', 'HSP90B1', 'HSPD1', 'ADCYAP1', 'YWHAQ', 'PRKAR1A', 'PAH', 'MYB', 'SCN5A', 'PRKACA', 'SCN3B', 'ALDOA', 'VAMP2', 'YWHAH']",0.9999950664293745,0,0,21
200,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.7037426581913959,0.8358460473654118,0.2936682666374954,"['TNC', 'VHL']",0.9999950664293745,0,0,2
201,Ganglio Sphingolipid Metabolism WP1423,0.7037426581913959,0.8358460473654118,0.2936682666374954,"['B3GALT4', 'ST3GAL5']",0.9999950664293745,0,0,2
202,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.7037426581913959,0.8358460473654118,0.2936682666374954,"['H2AFY', 'E2F1']",0.9999950664293745,0,0,2
203,Homologous recombination WP186,0.7037426581913959,0.8358460473654118,0.2936682666374954,"['POLD4', 'POLD2']",0.9999950664293745,0,0,2
204,IL-9 signaling pathway WP22,0.7037426581913959,0.8358460473654118,0.2936682666374954,"['STAT1', 'JAK3']",0.9999950664293745,0,0,2
205,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.7037426581913959,0.8358460473654118,0.2936682666374954,"['BUB1', 'ANAPC11']",0.9999950664293745,0,0,2
206,Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877,0.7037426581913959,0.8358460473654118,0.2936682666374954,"['TRAF6', 'UBE2V1']",0.9999950664293745,0,0,2
207,7-oxo-C and 7beta-HC pathways WP5064,0.7077308787388582,0.835737300129483,0.2889071741857663,"['ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9999950664293745,0,0,4
208,Mammary gland development pathway - Pregnancy and lactation (Stage 3 of 4) WP2817,0.7077308787388582,0.835737300129483,0.2889071741857663,"['TTC9', 'PNCK', 'TPM3', 'ERBB2']",0.9999950664293745,0,0,4
209,Senescence and Autophagy in Cancer WP615,0.7095959444884639,0.8812102505269579,0.30230760364284615,"['GABARAPL2', 'BECN1', 'GABARAPL1', 'GABARAP', 'MAP1LC3B', 'ING2', 'MAP1LC3A', 'CREG1', 'E2F1', 'SLC39A1', 'SQSTM1', 'HRAS', 'SLC39A4', 'SLC39A3']",0.9999950664293745,0,0,14
210,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.7201789448903861,0.8111803661862096,0.2662744680254736,"['H3F3B', 'H2AFY', 'H2AFZ']",0.9999950664293745,0,0,3
211,Globo Sphingolipid Metabolism WP1424,0.7201789448903861,0.8111803661862096,0.2662744680254736,"['B3GALNT1', 'ST6GAL2', 'FUT2']",0.9999950664293745,0,0,3
212,Hippo-Yap signaling pathway WP4537,0.7201789448903861,0.8111803661862096,0.2662744680254736,"['RASSF1', 'YWHAQ', 'NDRG1']",0.9999950664293745,0,0,3
213,Triacylglyceride synthesis WP325,0.7201789448903861,0.8111803661862096,0.2662744680254736,"['DGAT2', 'LPL', 'AGPAT1']",0.9999950664293745,0,0,3
214,Alpha 6 Beta 4 signaling pathway WP244,0.7267858690279805,0.8207303796269999,0.26191425722538925,"['LAMA1', 'PRKCD', 'RAC1', 'HRAS', 'RHOA']",0.9999950664293745,0,0,5
215,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7267858690279805,0.8207303796269999,0.26191425722538925,"['IGFBP2', 'PGK1', 'TGFA', 'BAX', 'HIF1AN']",0.9999950664293745,0,0,5
216,DNA damage response WP707,0.7291073734877163,0.8509422133716856,0.26884180621476,"['CASP9', 'CCND2', 'GADD45A', 'E2F1', 'CDK1', 'RPA2', 'CYCS', 'BAX', 'RAD1', 'ATRIP']",0.9999950664293745,0,0,10
217,IL17 signaling pathway WP2112,0.7363985282753046,0.7993432896006452,0.24458611977000425,"['TRAF6', 'IKBKG', 'IL17RE', 'NFKBIB']",0.9999950664293745,0,0,4
218,Lipid Metabolism Pathway WP3965,0.7363985282753046,0.7993432896006452,0.24458611977000425,"['BCKDHA', 'PRKAR1A', 'PRKAG1', 'PRKACA']",0.9999950664293745,0,0,4
219,Thermogenesis WP4321,0.7410401775201401,0.8647430505291575,0.25916386795800084,"['SMARCD1', 'PRKAG1', 'SIRT6', 'ADCY1', 'ADCY8', 'ADCY7', 'ACTG1', 'SLC25A29', 'CPT2', 'CREB3L4', 'CREB3L1', 'CREB3L2', 'PRKACA', 'HRAS', 'MGLL', 'CREB5']",0.9999950664293745,0,0,16
220,Spinal Cord Injury WP2431,0.7412648229823885,0.8613904587765957,0.2578980048165636,"['IL1R1', 'GADD45A', 'NCAN', 'PLA2G6', 'RHOA', 'RHOB', 'CDC42', 'GAP43', 'APEX1', 'CDK1', 'E2F1', 'NOX4', 'RAC1', 'LTB', 'E2F5']",0.9999950664293745,0,0,15
221,Airway smooth muscle cell contraction WP4962,0.7428652299079977,0.766137040714995,0.2277270620976686,"['CALM2', 'RHOA']",0.9999950664293745,0,0,2
222,Cell Differentiation - Index expanded WP2023,0.7428652299079977,0.766137040714995,0.2277270620976686,"['PAX7', 'MEF2D']",0.9999950664293745,0,0,2
223,FOXA2 pathway WP5066,0.7428652299079977,0.766137040714995,0.2277270620976686,"['ABCC4', 'SLC27A5']",0.9999950664293745,0,0,2
224,Galanin receptor pathway WP4970,0.7428652299079977,0.766137040714995,0.2277270620976686,"['PRKCD', 'VAMP2']",0.9999950664293745,0,0,2
225,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.7428652299079977,0.766137040714995,0.2277270620976686,"['TERT', 'ALPL']",0.9999950664293745,0,0,2
226,Riboflavin and CoQ disorders WP5037,0.7428652299079977,0.766137040714995,0.2277270620976686,"['FLAD1', 'COQ7']",0.9999950664293745,0,0,2
227,Alzheimer's disease WP2059,0.7436091769563927,0.8482129627264134,0.2512743383099712,"['CASP9', 'PSENEN', 'BACE1', 'ATP5MD', 'NCSTN', 'PSEN2', 'CHP1', 'LPL', 'CYCS', 'CALM3', 'MAPT', 'CALM2']",0.9999950664293745,0,0,12
228,Aryl Hydrocarbon Receptor Netpath WP2586,0.7436725716913489,0.810992610501277,0.24017905659279057,"['HSP90AA1', 'KLF6', 'CDC37', 'E2F1', 'LPL', 'HRAS']",0.9999950664293745,0,0,6
229,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7436725716913489,0.810992610501277,0.24017905659279057,"['CASP9', 'CAMK2A', 'NPPA', 'NEFL', 'CYCS', 'CALM2']",0.9999950664293745,0,0,6
230,Benzo(a)pyrene metabolism WP696,0.7478800315308337,0.7662144275314361,0.22259502175699128,['AKR1A1'],0.9999950664293745,0,0,1
231,Cholesterol Biosynthesis with Skeletal Dysplasias WP4804,0.7478800315308337,0.7662144275314361,0.22259502175699128,['NSDHL'],0.9999950664293745,0,0,1
232,Glial Cell Differentiation WP2276,0.7478800315308337,0.7662144275314361,0.22259502175699128,['GAP43'],0.9999950664293745,0,0,1
233,Ketogenesis and Ketolysis WP4742,0.7478800315308337,0.7662144275314361,0.22259502175699128,['CPT2'],0.9999950664293745,0,0,1
234,Mevalonate pathway WP3963,0.7478800315308337,0.7662144275314361,0.22259502175699128,['PMVK'],0.9999950664293745,0,0,1
235,Role of Altered Glycolysation of MUC1 in Tumour Microenvironment WP4480,0.7478800315308337,0.7662144275314361,0.22259502175699128,['IKBKG'],0.9999950664293745,0,0,1
236,Type III interferon signaling WP2113,0.7478800315308337,0.7662144275314361,0.22259502175699128,['STAT1'],0.9999950664293745,0,0,1
237,Nuclear Receptors Meta-Pathway WP2882,0.7514237262267082,0.9001991678334089,0.2572639325752372,"['HSP90AB1', 'MGST3', 'ABCB4', 'TGFA', 'TXN', 'ABCB11', 'SULT1A1', 'DNAJB1', 'GPR153', 'CPT2', 'SLC39A9', 'FTH1', 'PDE4B', 'SLC39A7', 'SLC39A1', 'SLC39A4', 'CAP2', 'SLC39A3', 'IL11', 'CBR1', 'ABCC4', 'G6PD', 'HSP90AA1', 'GPX3', 'PTGES3', 'MYOF', 'SLC39A10', 'APOA1', 'SERPINB9', 'CES4A', 'PSMC5', 'GSTA4', 'DNAJC7', 'CDC37', 'CDK1', 'BAX', 'SQSTM1', 'CES2', 'SLC27A5', 'HSPA1A']",0.9999950664293745,0,0,40
238,Tryptophan metabolism WP465,0.7515353496265421,0.7923722035602477,0.22633084457321745,"['ECHS1', 'AANAT', 'WARS', 'AFMID', 'CAT']",0.9999950664293745,0,0,5
239,Immune response to tuberculosis WP4197,0.7515452590455414,0.7660596026490066,0.2188048904782072,"['STAT1', 'IFNGR2', 'IFNAR1']",0.9999950664293745,0,0,3
240,One-carbon metabolism WP241,0.7628866170546279,0.7659821132825438,0.20730988797866512,"['BHMT', 'ATIC', 'AMT', 'FTCD']",0.9999950664293745,0,0,4
241,miRNA regulation of DNA damage response WP1530,0.764618411236445,0.8204328860651463,0.2201864475837737,"['CASP9', 'CCND2', 'GADD45A', 'E2F1', 'CDK1', 'RPA2', 'CYCS', 'BAX', 'RAD1', 'ATRIP']",0.9999950664293745,0,0,10
242,Neural Crest Cell Migration in Cancer WP4565,0.7745721370538488,0.7659045725646123,0.19564609779785164,"['ARF1', 'PAK1', 'RAC1', 'RHOA', 'NGEF']",0.9999950664293745,0,0,5
243,Biomarkers for pyrimidine metabolism disorders WP4584,0.7774693783013215,0.7071524966261808,0.1779980765931446,"['RRM2', 'TK2']",0.9999950664293745,0,0,2
244,Constitutive Androstane Receptor Pathway WP2875,0.780018535057837,0.7256883931683513,0.18028828034179353,"['SULT1A1', 'HSP90AA1', 'DNAJC7']",0.9999950664293745,0,0,3
245,Estrogen signaling pathway WP712,0.780018535057837,0.7256883931683513,0.18028828034179353,"['GNB1', 'IKBKG', 'PRKACA']",0.9999950664293745,0,0,3
246,NAD+ biosynthetic pathways WP3645,0.780018535057837,0.7256883931683513,0.18028828034179353,"['PARP1', 'SIRT5', 'SIRT6']",0.9999950664293745,0,0,3
247,Urea cycle and associated pathways WP4595,0.780018535057837,0.7256883931683513,0.18028828034179353,"['GOT1', 'MDH2', 'PYCR1']",0.9999950664293745,0,0,3
248,Autophagy WP4923,0.7872517653316137,0.7352898310698907,0.1758866044734381,"['BECN1', 'MAP1LC3B', 'PRKAG1', 'WIPI2']",0.9999950664293745,0,0,4
249,Trans-sulfuration and one-carbon metabolism WP2525,0.7872517653316137,0.7352898310698907,0.1758866044734381,"['BHMT', 'AHCYL1', 'GSS', 'AMT']",0.9999950664293745,0,0,4
250,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.7929379491638445,0.6567079512149002,0.1523630144384741,['TRAF6'],0.9999950664293745,0,0,1
251,Aspirin and miRNAs WP4707,0.7929379491638445,0.6567079512149002,0.1523630144384741,['ABCC4'],0.9999950664293745,0,0,1
252,Canonical NF-KB pathway WP4562,0.7929379491638445,0.6567079512149002,0.1523630144384741,['IKBKG'],0.9999950664293745,0,0,1
253,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.7929379491638445,0.6567079512149002,0.1523630144384741,['STAR'],0.9999950664293745,0,0,1
254,Heme Biosynthesis WP561,0.7929379491638445,0.6567079512149002,0.1523630144384741,['ALAD'],0.9999950664293745,0,0,1
255,HIF1A and PPARG regulation of glycolysis WP2456,0.7929379491638445,0.6567079512149002,0.1523630144384741,['TPI1'],0.9999950664293745,0,0,1
256,Irinotecan pathway WP229,0.7929379491638445,0.6567079512149002,0.1523630144384741,['CES2'],0.9999950664293745,0,0,1
257,NAD Biosynthesis II (from tryptophan) WP2485,0.7929379491638445,0.6567079512149002,0.1523630144384741,['AFMID'],0.9999950664293745,0,0,1
258,IL-2 signaling pathway WP49,0.7959330999528332,0.7411445306654696,0.16915893288836412,"['CCND2', 'STAT1', 'MAPT', 'HRAS', 'JAK3']",0.9999950664293745,0,0,5
259,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7959330999528332,0.7411445306654696,0.16915893288836412,"['PRKCG', 'KISS1', 'STAR', 'PRKCD', 'HRAS']",0.9999950664293745,0,0,5
260,IL-3 signaling pathway WP286,0.804957572167293,0.7450752044719562,0.1616557695009508,"['YWHAQ', 'YWHAB', 'INPP5D', 'PRKACA', 'HRAS', 'VAV1']",0.9999950664293745,0,0,6
261,TLR4 Signaling and Tolerance WP3851,0.8057421959643422,0.6893543046357616,0.14889463152323001,"['INPP5D', 'TRAF6', 'IKBKG']",0.9999950664293745,0,0,3
262,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.8079204000236347,0.6565943159786258,0.14004614421860573,"['RBBP4', 'THRAP3']",0.9999950664293745,0,0,2
263,SARS coronavirus and innate immunity WP4912,0.8079204000236347,0.6565943159786258,0.14004614421860573,"['STAT1', 'IFNAR1']",0.9999950664293745,0,0,2
264,Transcription co-factors SKI and SKIL protein partners WP4533,0.8079204000236347,0.6565943159786258,0.14004614421860573,"['PRMT5', 'ING2']",0.9999950664293745,0,0,2
265,Fibrin Complement Receptor 3 Signaling Pathway WP4136,0.809571473860533,0.7069584936428263,0.14934513443259645,"['TRAF6', 'LY96', 'IKBKG', 'RHOA']",0.9999950664293745,0,0,4
266,Tumor suppressor activity of SMARCB1 WP4204,0.809571473860533,0.7069584936428263,0.14934513443259645,"['SMARCD1', 'RBBP4', 'H3F3B', 'DPF2']",0.9999950664293745,0,0,4
267,Chemokine signaling pathway WP3929,0.8141323273844212,0.8230127126096023,0.16923804791613736,"['ITK', 'STAT1', 'PRKCD', 'ADCY1', 'ADCY8', 'ADCY7', 'VAV1', 'CDC42', 'GNG10', 'GNG3', 'PAK1', 'GNB1', 'RAC2', 'GNB5', 'RAC1', 'IKBKG', 'HRAS', 'JAK3', 'NFKBIB']",0.9999950664293745,0,0,19
268,TNF-alpha signaling pathway WP231,0.8141581040663685,0.7960664451827243,0.1636718190131226,"['HSP90AA1', 'CSNK2A1', 'TRAF2', 'TRAF1', 'TXN', 'CASP9', 'CDC37', 'BAX', 'RAC1', 'IKBKG', 'HRAS', 'SKP1', 'NFKBIB']",0.9999950664293745,0,0,13
269,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8156691528445615,0.7179319913850232,0.14627609902328864,"['TRAF5', 'TRAF2', 'RAC1', 'TRAF1', 'NFKBIB']",0.9999950664293745,0,0,5
270,Vitamin D-sensitive calcium signaling in depression WP4698,0.8156691528445615,0.7179319913850232,0.14627609902328864,"['G6PD', 'CALB1', 'GPX4', 'ATP2B3', 'ATP2B2']",0.9999950664293745,0,0,5
271,Metapathway biotransformation Phase I and II WP702,0.8262151528802457,0.8102378388959577,0.15467445508745278,"['GSTK1', 'GAL3ST1', 'GPX4', 'GPX3', 'NAA20', 'MGST3', 'GSS', 'AKR1A1', 'NAA80', 'SULT1A1', 'GSTZ1', 'AKR7A2', 'CYP26B1', 'CYP4X1', 'CYP24A1', 'GSTA4', 'CYP20A1', 'SULT4A1']",0.9999950664293745,0,0,18
272,miRNAs involvement in the immune response in sepsis WP4329,0.8288808644296403,0.656480605487228,0.12320752124500992,"['TRAF6', 'IKBKG', 'ELANE']",0.9999950664293745,0,0,3
273,Nuclear Receptors in Lipid Metabolism and Toxicity WP299,0.8288808644296403,0.656480605487228,0.12320752124500992,"['CYP24A1', 'ABCB4', 'ABCB11']",0.9999950664293745,0,0,3
274,Physiological and pathological hypertrophy of the heart WP1528,0.8288808644296403,0.656480605487228,0.12320752124500992,"['RAC1', 'CALM2', 'RHOA']",0.9999950664293745,0,0,3
275,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.8288808644296403,0.656480605487228,0.12320752124500992,"['ITK', 'RASGRP1', 'CALM2']",0.9999950664293745,0,0,3
276,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.8288808644296403,0.656480605487228,0.12320752124500992,"['STAT1', 'TRAF6', 'IFNAR1']",0.9999950664293745,0,0,3
277,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8299388559339157,0.6807257738029516,0.1268894955436277,"['STAT1', 'TRAF6', 'IKBKG', 'IFNAR1']",0.9999950664293745,0,0,4
278,Wnt signaling in kidney disease WP4150,0.8299388559339157,0.6807257738029516,0.1268894955436277,"['WNT10B', 'WNT10A', 'FZD4', 'RHOA']",0.9999950664293745,0,0,4
279,15q11.2 copy number variation syndrome WP4940,0.8299454183026878,0.5745780939774984,0.10709868000797701,['TUBGCP4'],0.9999950664293745,0,0,1
280,Bile acids synthesis and enterohepatic circulation  WP4389,0.8299454183026878,0.5745780939774984,0.10709868000797701,['ABCB11'],0.9999950664293745,0,0,1
281,Biotin Metabolism (including IEMs) WP5031,0.8299454183026878,0.5745780939774984,0.10709868000797701,['PCCB'],0.9999950664293745,0,0,1
282,Cell Differentiation - Index WP2029,0.8299454183026878,0.5745780939774984,0.10709868000797701,['MEF2D'],0.9999950664293745,0,0,1
283,Cytosine methylation WP3585,0.8299454183026878,0.5745780939774984,0.10709868000797701,['IDH2'],0.9999950664293745,0,0,1
284,Leptin and adiponectin WP3934,0.8299454183026878,0.5745780939774984,0.10709868000797701,['PRKAG1'],0.9999950664293745,0,0,1
285,NLR Proteins WP288,0.8299454183026878,0.5745780939774984,0.10709868000797701,['IKBKG'],0.9999950664293745,0,0,1
286,Tamoxifen metabolism WP691,0.8299454183026878,0.5745780939774984,0.10709868000797701,['SULT1A1'],0.9999950664293745,0,0,1
287,Melanoma WP4685,0.8307951309108839,0.7516197140616517,0.13932928550300036,"['PAK1', 'GADD45A', 'E2F1', 'BAX', 'E2F3', 'CALM3', 'RAC1', 'HRAS', 'CALM2']",0.9999950664293745,0,0,9
288,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8307951309108839,0.7516197140616517,0.13932928550300036,"['STAT1', 'KCNIP3', 'APEX1', 'GNB1', 'E2F1', 'TTF2', 'TTF1', 'HRAS', 'MYL12B']",0.9999950664293745,0,0,9
289,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.8345973064419767,0.6127772260840781,0.1107937612660041,"['CYP24A1', 'ALPL']",0.9999950664293745,0,0,2
290,Proteoglycan biosynthesis WP4784,0.8345973064419767,0.6127772260840781,0.1107937612660041,"['B3GALT6', 'B4GALT7']",0.9999950664293745,0,0,2
291,Pyrimidine metabolism and related diseases WP4225,0.8345973064419767,0.6127772260840781,0.1107937612660041,"['RRM2', 'TK2']",0.9999950664293745,0,0,2
292,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8413307288829165,0.8100482031586785,0.1399523841702471,"['RAB3A', 'CSNK2A1', 'STAT1', 'PRKCD', 'CAMK2A', 'EIF2S2', 'EIF2S1', 'PTPRF', 'CDC42', 'DOK5', 'DPYSL2', 'TRAF6', 'CFL1', 'RACK1', 'ALPL', 'RAC1', 'IKBKG', 'MAPT', 'SQSTM1', 'HRAS', 'SH2B1']",0.9999950664293745,0,0,21
293,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.8442159202832006,0.738144610863589,0.12500256610465776,"['IDI1', 'SEC13', 'RBP4', 'SAR1A', 'NFYA', 'PRKAG1', 'LPL', 'PRKACA', 'SEC23B']",0.9999950664293745,0,0,9
294,Hepatitis B infection WP4666,0.8444239345190899,0.800186906754297,0.1353121007744505,"['PRKCG', 'YWHAB', 'STAT1', 'YWHAZ', 'CASP9', 'DDB1', 'YWHAQ', 'CREB3L4', 'CREB3L1', 'TRAF6', 'CREB3L2', 'CYCS', 'BAX', 'IKBKG', 'HRAS', 'JAK3', 'IFNAR1', 'ATF4', 'CREB5']",0.9999950664293745,0,0,19
295,Monoamine Transport WP727,0.8496117743266233,0.6265954244431066,0.10211987172683741,"['PPP2CB', 'IL1R1', 'STX1A']",0.9999950664293745,0,0,3
296,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8507895559927784,0.7204760511169642,0.11642206462093903,"['PRKCG', 'RXRB', 'CYP24A1', 'STAT1', 'PRKCD', 'CAMK2A', 'ISG15', 'HRAS']",0.9999950664293745,0,0,8
297,Proximal tubule transport WP4917,0.854181163365654,0.6890454093470335,0.10860180617984562,"['ABCC4', 'ATP6V1G1', 'SLC3A2', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9999950664293745,0,0,6
298,Ras signaling WP4223,0.8548335407904963,0.8098581880234588,0.12702505668991387,"['PRKCG', 'RAB5C', 'PLA2G4C', 'PLA2G6', 'RASGRP1', 'RHOA', 'CDC42', 'RASSF1', 'GNG10', 'GNG3', 'PAK1', 'SYNGAP1', 'MRAS', 'RRAS', 'GNB1', 'RAC2', 'CALM3', 'GNB5', 'RAC1', 'IKBKG', 'PRKACA', 'CALM2', 'RAB5A', 'HRAS']",0.9999950664293745,0,0,24
299,Kynurenine Pathway and links to Cellular Senescence WP5044,0.8578762714029271,0.5744372724263489,0.0880585889911503,"['EIF2AK1', 'AFMID']",0.9999950664293745,0,0,2
300,Nicotine Activity on Dopaminergic Neurons WP1602,0.8578762714029271,0.5744372724263489,0.0880585889911503,"['GNB1', 'PRKACA']",0.9999950664293745,0,0,2
301,IL-1 signaling pathway WP195,0.8586484042368969,0.6989606158459232,0.10651862658021034,"['IL1R1', 'TRAF6', 'IKBKG', 'UBE2V1', 'ECSIT', 'SQSTM1', 'NFKBIB']",0.9999950664293745,0,0,7
302,Autosomal recessive Osteopetrosis pathways WP4788,0.8603404100479561,0.5106993161261858,0.07682303875852793,['TRAF6'],0.9999950664293745,0,0,1
303,EDA signaling in hair follicle development WP3930,0.8603404100479561,0.5106993161261858,0.07682303875852793,['LTB'],0.9999950664293745,0,0,1
304,LTF danger signal response pathway WP4478,0.8603404100479561,0.5106993161261858,0.07682303875852793,['TRAF6'],0.9999950664293745,0,0,1
305,Mammary gland development pathway - Puberty (Stage 2 of 4) WP2814,0.8603404100479561,0.5106993161261858,0.07682303875852793,['ERBB2'],0.9999950664293745,0,0,1
306,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.8603404100479561,0.5106993161261858,0.07682303875852793,['BHMT'],0.9999950664293745,0,0,1
307,Nanoparticle triggered regulated necrosis WP2513,0.8603404100479561,0.5106993161261858,0.07682303875852793,['PARP1'],0.9999950664293745,0,0,1
308,Selective expression of chemokine receptors during T-cell polarization WP4494,0.8603404100479561,0.5106993161261858,0.07682303875852793,['IFNGR2'],0.9999950664293745,0,0,1
309,TCA cycle in senescence WP5050,0.8603404100479561,0.5106993161261858,0.07682303875852793,['GOT1'],0.9999950664293745,0,0,1
310,Trans-sulfuration pathway WP2333,0.8603404100479561,0.5106993161261858,0.07682303875852793,['GOT1'],0.9999950664293745,0,0,1
311,Valproic acid pathway WP3871,0.8603404100479561,0.5106993161261858,0.07682303875852793,['IVD'],0.9999950664293745,0,0,1
312,Prolactin Signaling Pathway WP2037,0.8626827056153441,0.7289049041455281,0.10766531876730213,"['PAK1', 'STAT1', 'ERBB2', 'AGAP2', 'RAC1', 'PPIB', 'HRAS', 'YWHAZ', 'VAV1', 'NFKBIB']",0.9999950664293745,0,0,10
313,EGF/EGFR signaling pathway WP437,0.8640626744058812,0.7995984848484848,0.1168293130219343,"['NDUFA13', 'STAT1', 'STXBP1', 'PRKCD', 'CAMK2A', 'PEBP1', 'NEDD8', 'VAV1', 'CDC42', 'PAK1', 'INPP5D', 'CFL1', 'STMN1', 'ERBB2', 'E2F1', 'AP2S1', 'STAMBP', 'RAC1', 'RAB5A', 'HRAS', 'MEF2D', 'PTPN5', 'AP2M1']",0.9999950664293745,0,0,23
314,Disruption of postsynaptic signaling by CNV WP4875,0.8652404032854955,0.633687793400418,0.09172496961318127,"['RPH3A', 'SYNGAP1', 'CAMK2A', 'STX1A']",0.9999950664293745,0,0,4
315,Nephrotic syndrome WP4758,0.865787087834231,0.6562529584398372,0.09457672044329914,"['INF2', 'NPHS1', 'PODXL', 'ARHGDIA', 'E2F3']",0.9999950664293745,0,0,5
316,Signal transduction through IL1R WP4496,0.8681179366164539,0.5993089547941262,0.08475888818878155,"['IL1R1', 'TRAF6', 'ECSIT']",0.9999950664293745,0,0,3
317,Prader-Willi and Angelman Syndrome WP3998,0.8714644952368606,0.684039731361815,0.09411029205037459,"['KISS1', 'PCSK1', 'CCND2', 'SNRPN', 'FEZ1', 'E2F1', 'BBS4']",0.9999950664293745,0,0,7
318,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.8781195520910091,0.5406079015518819,0.07026417697501759,"['PRKAG1', 'PDHB']",0.9999950664293745,0,0,2
319,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.8781195520910091,0.5406079015518819,0.07026417697501759,"['CASP9', 'BAX']",0.9999950664293745,0,0,2
320,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.8781195520910091,0.5406079015518819,0.07026417697501759,"['BECN1', 'MAP1LC3A']",0.9999950664293745,0,0,2
321,Imatinib and Chronic Myeloid Leukemia WP3640,0.8781195520910091,0.5406079015518819,0.07026417697501759,"['GADD45A', 'PIM2']",0.9999950664293745,0,0,2
322,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.8781195520910091,0.5406079015518819,0.07026417697501759,"['RASGRP1', 'HRAS']",0.9999950664293745,0,0,2
323,Hepatitis C and Hepatocellular Carcinoma WP3646,0.87971540173488,0.6379776894190413,0.08176119888426249,"['CASP9', 'RRM2', 'PODXL', 'MYOF', 'RAC1']",0.9999950664293745,0,0,5
324,Target Of Rapamycin (TOR) Signaling WP1471,0.8804010418217103,0.6125207022192779,0.07802150641484579,"['CDC42', 'IDI1', 'PRKAG1', 'RAC1']",0.9999950664293745,0,0,4
325,Folate Metabolism WP176,0.8809554837611459,0.6561390217339836,0.08316442915324823,"['GPX4', 'FLAD1', 'GPX3', 'CAT', 'APOA1', 'SOD1']",0.9999950664293745,0,0,6
326,Alanine and aspartate metabolism WP106,0.8853041155181893,0.4595962938451357,0.05598988631572959,['GOT1'],0.9999950664293745,0,0,1
327,Biomarkers for urea cycle disorders WP4583,0.8853041155181893,0.4595962938451357,0.05598988631572959,['GOT1'],0.9999950664293745,0,0,1
328,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.8853041155181893,0.4595962938451357,0.05598988631572959,['BATF3'],0.9999950664293745,0,0,1
329,"NAD metabolism, sirtuins and aging WP3630",0.8853041155181893,0.4595962938451357,0.05598988631572959,['PARP1'],0.9999950664293745,0,0,1
330,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.8853041155181893,0.4595962938451357,0.05598988631572959,['HLA-DRB1'],0.9999950664293745,0,0,1
331,Transcriptional cascade regulating adipogenesis WP4211,0.8853041155181893,0.4595962938451357,0.05598988631572959,['DDIT3'],0.9999950664293745,0,0,1
332,Vitamin B12 Disorders WP4271,0.8853041155181893,0.4595962938451357,0.05598988631572959,['MMACHC'],0.9999950664293745,0,0,1
333,Apoptosis WP254,0.8896725233666225,0.688735899137359,0.08051449060489024,"['HRK', 'CASP9', 'CYCS', 'BAX', 'TRAF2', 'IKBKG', 'TRAF1', 'BCL2L2', 'NFKBIB']",0.9999950664293745,0,0,9
334,Integrated Cancer Pathway WP1971,0.8923901569720537,0.6206902727777479,0.0706667335505761,"['CASP9', 'STAT1', 'E2F1', 'CDK1', 'BAX']",0.9999950664293745,0,0,5
335,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.8927092605618845,0.6408337251697743,0.0727309924823633,"['ITK', 'PAK1', 'RRAS', 'CHP1', 'IKBKG', 'CALM2']",0.9999950664293745,0,0,6
336,Bladder cancer WP2828,0.894056349113604,0.5927192298240178,0.0663765374892306,"['RASSF1', 'ERBB2', 'E2F1', 'HRAS']",0.9999950664293745,0,0,4
337,Oxysterols derived from cholesterol WP4545,0.894056349113604,0.5927192298240178,0.0663765374892306,"['ACOT8', 'ACOT7', 'ACOT13', 'SLC27A5']",0.9999950664293745,0,0,4
338,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.8956684571845047,0.5105373496634669,0.0562535374242409,"['B3GALNT1', 'SGMS2']",0.9999950664293745,0,0,2
339,Photodynamic therapy-induced NF-kB survival signaling WP3617,0.8956684571845047,0.5105373496634669,0.0562535374242409,"['TRAF6', 'BCL2L2']",0.9999950664293745,0,0,2
340,Ciliopathies WP4803,0.896064965504529,0.7801119113422553,0.08561132415900667,"['ARL3', 'TCTN3', 'TMEM107', 'TCTN1', 'NEK2', 'BBS4', 'PLK4', 'MKKS', 'DCDC2', 'CFAP410', 'POMGNT1', 'TMEM231', 'RSPH3', 'CENPF', 'RSPH1', 'TMEM17', 'TMEM138', 'BBS12', 'CEP83', 'IFT27', 'HYLS1', 'B9D1', 'CEP41', 'CCNQ', 'CCNO']",0.9999950664293745,0,0,25
341,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.8964558003244085,0.6678848183325795,0.07300401139540719,"['CASP9', 'PAK1', 'STMN1', 'ERBB2', 'BAX', 'RAC1', 'IKBKG', 'HRAS']",0.9999950664293745,0,0,8
342,Endothelin Pathways WP2197,0.8991863243147172,0.5512847682119205,0.05858228068090073,"['RIIAD1', 'GNB5', 'CALM2']",0.9999950664293745,0,0,3
343,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.8991863243147172,0.5512847682119205,0.05858228068090073,"['ERBB2', 'TGFA', 'HRAS']",0.9999950664293745,0,0,3
344,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.8991863243147172,0.5512847682119205,0.05858228068090073,"['CCND2', 'FGF1', 'GTPBP4']",0.9999950664293745,0,0,3
345,Netrin-UNC5B signaling pathway WP4747,0.9038944135464074,0.6043127201702069,0.06106140374788004,"['INPP5D', 'AGAP2', 'ALPL', 'RAC1', 'RHOA']",0.9999950664293745,0,0,5
346,Peptide GPCRs WP24,0.9038944135464074,0.6043127201702069,0.06106140374788004,"['NPY5R', 'CCKBR', 'TACR2', 'SSTR1', 'FPR2']",0.9999950664293745,0,0,5
347,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.9038944135464074,0.6043127201702069,0.06106140374788004,"['HSP90AA1', 'TRAF6', 'TRAF5', 'BAX', 'TRAF2']",0.9999950664293745,0,0,5
348,MET in type 1 papillary renal cell carcinoma WP4205,0.9042556230035861,0.6428580901856764,0.06469928875432523,"['ALK', 'CDC42', 'PAK1', 'RPL11', 'RAC1', 'JAK3', 'HRAS']",0.9999950664293745,0,0,7
349,Cancer immunotherapy by CTLA4 blockade WP4582,0.9058067861980672,0.41778473016064016,0.041331132501811314,['HLA-DRB1'],0.9999950664293745,0,0,1
350,Genes targeted by miRNAs in adipocytes WP1992,0.9058067861980672,0.41778473016064016,0.041331132501811314,['TMSB4X'],0.9999950664293745,0,0,1
351,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.9058067861980672,0.41778473016064016,0.041331132501811314,['GABBR1'],0.9999950664293745,0,0,1
352,Iron metabolism in placenta WP2007,0.9058067861980672,0.41778473016064016,0.041331132501811314,['FTH1'],0.9999950664293745,0,0,1
353,Serotonin and anxiety-related events WP3944,0.9058067861980672,0.41778473016064016,0.041331132501811314,['CRH'],0.9999950664293745,0,0,1
354,Differentiation Pathway WP2848,0.9063217201819301,0.5741553494534614,0.056474457830559155,"['ALK', 'IL11', 'NT5E', 'FGF1']",0.9999950664293745,0,0,4
355,Glycerolipids and Glycerophospholipids WP4722,0.9108392693360468,0.48363211902646386,0.045165837992439846,"['DGAT2', 'CDIPT']",0.9999950664293745,0,0,2
356,IL-7 signaling pathway WP205,0.9108392693360468,0.48363211902646386,0.045165837992439846,"['STAT1', 'JAK3']",0.9999950664293745,0,0,2
357,Kallmann's Syndrome WP5074,0.9108392693360468,0.48363211902646386,0.045165837992439846,"['CHD7', 'ASCL1']",0.9999950664293745,0,0,2
358,Purinergic signaling WP4900,0.9108392693360468,0.48363211902646386,0.045165837992439846,"['PANX1', 'P2RX5']",0.9999950664293745,0,0,2
359,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.9108392693360468,0.48363211902646386,0.045165837992439846,"['BAX', 'BCL2L2']",0.9999950664293745,0,0,2
360,Sphingolipid pathway WP1422,0.912101809200612,0.5300433010697911,0.04876592484572926,"['ASAH1', 'GAL3ST1', 'SGMS2']",0.9999950664293745,0,0,3
361,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.9132658339440151,0.6122638382499171,0.055549642158725605,"['BEX3', 'SERBP1', 'TRAF1', 'RNF7', 'SQSTM1', 'HSPD1']",0.9999950664293745,0,0,6
362,Interferon type I signaling pathways WP585,0.9132658339440151,0.6122638382499171,0.055549642158725605,"['STAT1', 'RACK1', 'RAC1', 'VAV1', 'EIF4B', 'IFNAR1']",0.9999950664293745,0,0,6
363,Phosphodiesterases in neuronal function WP4222,0.9132658339440151,0.6122638382499171,0.055549642158725605,"['PDE10A', 'PDE6H', 'PDE4B', 'ADCY1', 'ADCY8', 'ADCY7']",0.9999950664293745,0,0,6
364,"GPCRs, Other WP117",0.9134677258252563,0.6302075206740522,0.05703833956032773,"['GPR143', 'ALG6', 'CCKBR', 'ADGRF5', 'GPR61', 'ADRA1D', 'MCHR2']",0.9999950664293745,0,0,7
365,Genotoxicity pathway WP4286,0.9221949828988046,0.5989105215373751,0.04851091352163002,"['HIST1H2BN', 'RPS27', 'GADD45A', 'BLOC1S2', 'SEL1L', 'TRIAP1']",0.9999950664293745,0,0,6
366,Acute viral myocarditis WP4298,0.9224429085985657,0.6332018070566706,0.0511182506086721,"['CASP9', 'PARP1', 'STAT1', 'RAC2', 'KRT8', 'CYCS', 'BAX', 'EIF4G2']",0.9999950664293745,0,0,8
367,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.9226453940993614,0.38294176042356054,0.03083075858247312,['CCKBR'],0.9999950664293745,0,0,1
368,Hedgehog Signaling Pathway Netpath WP47,0.9226453940993614,0.38294176042356054,0.03083075858247312,['SAP18'],0.9999950664293745,0,0,1
369,Omega-3/Omega-6 FA synthesis WP4723,0.9226453940993614,0.38294176042356054,0.03083075858247312,['PLA2G6'],0.9999950664293745,0,0,1
370,GABA receptor Signaling WP4159,0.9234940280467258,0.5103752759381899,0.040621251035054776,"['GABBR1', 'AP2S1', 'AP2M1']",0.9999950664293745,0,0,3
371,Leptin signaling pathway WP2034,0.9235426665463728,0.6455032763769077,0.051342220010493274,"['CDC42', 'STAT1', 'ERBB2', 'BAX', 'RAC1', 'IKBKG', 'HRAS', 'RHOA', 'SH2B1']",0.9999950664293745,0,0,9
372,1q21.1 copy number variation syndrome WP4905,0.9239212925358588,0.45941741145316123,0.036352961120111736,"['PYGO2', 'PRKAG1']",0.9999950664293745,0,0,2
373,NRF2-ARE regulation WP4357,0.9239212925358588,0.45941741145316123,0.036352961120111736,"['AIMP2', 'RBX1']",0.9999950664293745,0,0,2
374,PKC-gamma calcium signaling pathway in ataxia WP4760,0.9239212925358588,0.45941741145316123,0.036352961120111736,"['PRKCG', 'ATP2B2']",0.9999950664293745,0,0,2
375,Statin inhibition of cholesterol production WP430,0.9239212925358588,0.45941741145316123,0.036352961120111736,"['LPL', 'APOA1']",0.9999950664293745,0,0,2
376,Corticotropin-releasing hormone signaling pathway WP2355,0.9250254849269227,0.6556825186098336,0.051099955226771784,"['CASP9', 'HSP90AA1', 'PARP1', 'STAR', 'PRKCD', 'CAMK2A', 'GNB1', 'CRH', 'GNB5', 'RHOA']",0.9999950664293745,0,0,10
377,ATM Signaling Pathway WP2516,0.9271295588909798,0.5403035676012704,0.040880427839876644,"['MDC1', 'GADD45A', 'CDK1', 'IKBKG']",0.9999950664293745,0,0,4
378,Prostaglandin Synthesis and Regulation WP98,0.9271295588909798,0.5403035676012704,0.040880427839876644,"['CBR1', 'ABCC4', 'ANXA6', 'S100A6']",0.9999950664293745,0,0,4
379,Breast cancer pathway WP4262,0.9318707263208069,0.7117275804693327,0.05022033761855782,"['WNT10B', 'WNT10A', 'CSNK2A1', 'PARP1', 'GADD45A', 'NOTCH4', 'FGF1', 'DLL1', 'DLL3', 'DLL4', 'HEY1', 'ERBB2', 'E2F1', 'BAX', 'E2F3', 'HRAS', 'FGF22', 'SKP1']",0.9999950664293745,0,0,18
380,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9321999355214879,0.559973492379059,0.03931459891239856,"['CSNK2A1', 'PRKCD', 'PIM2', 'PRKACA', 'EIF4B']",0.9999950664293745,0,0,5
381,Cardiac Progenitor Differentiation WP2406,0.9335177562293094,0.4921121097445601,0.033854997785826436,"['MESP2', 'MESP1', 'SCN5A']",0.9999950664293745,0,0,3
382,MAPK Signaling Pathway WP382,0.9349338180251557,0.767645111454425,0.05164680618932949,"['PPP5D1', 'ECSIT', 'FGF1', 'RASGRP1', 'CDC42', 'PAK1', 'RRAS', 'STMN1', 'RAC2', 'RAC1', 'IKBKG', 'PRKACA', 'HRAS', 'FGF22', 'CACNG5', 'PRKCG', 'HSPA8', 'IL1R1', 'GADD45A', 'PRKCD', 'HSPA6', 'PLA2G4C', 'TRAF2', 'DUSP7', 'MRAS', 'DDIT3', 'TRAF6', 'MAPT', 'PTPN7', 'PTPN5', 'HSPA1B', 'ATF4', 'HSPA1A']",0.9999950664293745,0,0,33
383,miRNA regulation of p53 pathway in prostate cancer WP3982,0.9351763951439515,0.4375088665058874,0.02932189217507244,"['CASP9', 'BAX']",0.9999950664293745,0,0,2
384,Sphingolipid Metabolism (general overview) WP4725,0.9351763951439515,0.4375088665058874,0.02932189217507244,"['ASAH1', 'SGMS2']",0.9999950664293745,0,0,2
385,Glycogen Synthesis and Degradation WP500,0.9358845828162438,0.5248284673259831,0.034776771218978236,"['PPP2CB', 'PPP2R5A', 'CALM3', 'CALM2']",0.9999950664293745,0,0,4
386,Mammalian disorder of sexual development WP4842,0.9364745696581773,0.35345924756910857,0.023198559737100076,['SRD5A1'],0.9999950664293745,0,0,1
387,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.9364745696581773,0.35345924756910857,0.023198559737100076,['SAMHD1'],0.9999950664293745,0,0,1
388,Phytochemical activity on NRF2 transcriptional activation WP3,0.9364745696581773,0.35345924756910857,0.023198559737100076,['AIMP2'],0.9999950664293745,0,0,1
389,T-cell receptor (TCR) signaling pathway WP69,0.9368321845113714,0.6258520842130663,0.04083754412385182,"['CDC42', 'ITK', 'PAK1', 'DBNL', 'TRAF6', 'PRKCD', 'IKBKG', 'HRAS', 'VAV1']",0.9999950664293745,0,0,9
390,IL-18 signaling pathway WP4754,0.9369432257139707,0.7597300466127141,0.04948318573804255,"['MTCH1', 'NRN1', 'TOMM40', 'CD81', 'HSPB8', 'COX17', 'RXRB', 'TMSB4X', 'STMN1', 'NPPA', 'RAE1', 'ABCF1', 'CA11', 'PARP1', 'ECH1', 'PRKCD', 'HPS1', 'NDUFC1', 'TRAF1', 'BPGM', 'ARL4D', 'ACTA1', 'NACA', 'TRAF6', 'CYCS', 'BAX', 'LTB', 'PTPN7', 'CDK5R2', 'AARS', 'ITM2C']",0.9999950664293745,0,0,31
391,Neural Crest Differentiation WP2064,0.9376177325147063,0.6373769222259099,0.04105532633946107,"['DLL4', 'PAX7', 'MPZ', 'NOTCH4', 'HDAC11', 'MYB', 'ASCL1', 'DLL1', 'RHOB', 'DLL3']",0.9999950664293745,0,0,10
392,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9376177325147063,0.6373769222259099,0.04105532633946107,"['CASP9', 'THRA', 'NPPA', 'SIRT6', 'TTF2', 'TTF1', 'PRKACA', 'ADCY8', 'HRAS', 'MGLL']",0.9999950664293745,0,0,10
393,miRNA regulation of prostate cancer signaling pathways WP3981,0.9423169947665001,0.47510847225393926,0.028227880269675317,"['CASP9', 'CREB3L1', 'IKBKG']",0.9999950664293745,0,0,3
394,Apoptosis Modulation and Signaling WP1772,0.9426872493108257,0.6164664401945151,0.03638428476231403,"['HRK', 'CASP9', 'CAPNS1', 'IL1R1', 'TRAF6', 'CYCS', 'BAX', 'BCL2L2', 'HSPA1A']",0.9999950664293745,0,0,9
395,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9443186579190538,0.562120771410984,0.03220480313319921,"['THRA', 'STAT1', 'SERPINH1', 'ALPL', 'PRKACA', 'CALM2']",0.9999950664293745,0,0,6
396,Endochondral Ossification WP474,0.9443186579190538,0.562120771410984,0.03220480313319921,"['THRA', 'STAT1', 'SERPINH1', 'ALPL', 'PRKACA', 'CALM2']",0.9999950664293745,0,0,6
397,Gastric Cancer Network 1 WP2361,0.9448395766227494,0.41759200746291114,0.023694223156307488,"['CENPF', 'MCM4']",0.9999950664293745,0,0,2
398,Sphingolipid Metabolism (integrated pathway) WP4726,0.9448395766227494,0.41759200746291114,0.023694223156307488,"['ASAH1', 'SGMS2']",0.9999950664293745,0,0,2
399,Blood Clotting Cascade WP272,0.9478320172350585,0.3281885222652926,0.01758368117953445,['F8'],0.9999950664293745,0,0,1
400,Dopaminergic Neurogenesis WP2855,0.9478320172350585,0.3281885222652926,0.01758368117953445,['ASCL1'],0.9999950664293745,0,0,1
401,ERK Pathway in Huntington's Disease WP3853,0.9478320172350585,0.3281885222652926,0.01758368117953445,['HRAS'],0.9999950664293745,0,0,1
402,Hypertrophy Model WP516,0.9478320172350585,0.3281885222652926,0.01758368117953445,['IL1R1'],0.9999950664293745,0,0,1
403,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.9478320172350585,0.3281885222652926,0.01758368117953445,['RHOA'],0.9999950664293745,0,0,1
404,miRNAs involved in DNA damage response WP1545,0.9478320172350585,0.3281885222652926,0.01758368117953445,['E2F1'],0.9999950664293745,0,0,1
405,Overview of nanoparticle effects WP3287,0.9478320172350585,0.3281885222652926,0.01758368117953445,['BAX'],0.9999950664293745,0,0,1
406,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.9478320172350585,0.3281885222652926,0.01758368117953445,['DLD'],0.9999950664293745,0,0,1
407,Tryptophan catabolism leading to NAD+ production WP4210,0.9478320172350585,0.3281885222652926,0.01758368117953445,['AFMID'],0.9999950664293745,0,0,1
408,Type II diabetes mellitus WP1584,0.9478320172350585,0.3281885222652926,0.01758368117953445,['PRKCD'],0.9999950664293745,0,0,1
409,IL-6 signaling pathway WP364,0.9505874783295851,0.49638774249572526,0.025154492173351403,"['STAT1', 'PRKCD', 'RAC1', 'VAV1']",0.9999950664293745,0,0,4
410,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.9505874783295851,0.49638774249572526,0.025154492173351403,"['ACTA1', 'PAK1', 'YWHAQ', 'ACTG1']",0.9999950664293745,0,0,4
411,Ovarian infertility WP34,0.9531202075018698,0.3994070492062807,0.019177228871402677,"['CCND2', 'DMC1']",0.9999950664293745,0,0,2
412,DNA damage response (only ATM dependent) WP710,0.9540216508283406,0.6327145294838465,0.029781185143855124,"['CDC42', 'WNT10B', 'WNT10A', 'CCND2', 'CAT', 'ERBB2', 'RAC2', 'BAX', 'HMGB1', 'RAC1', 'HRAS', 'RHOA']",0.9999950664293745,0,0,12
413,Microglia Pathogen Phagocytosis Pathway WP3937,0.9567623417195124,0.4443922238837855,0.019642249673932414,"['RAC2', 'RAC1', 'VAV1']",0.9999950664293745,0,0,3
414,Pre-implantation embryo WP3527,0.9567623417195124,0.4443922238837855,0.019642249673932414,"['BATF3', 'DDIT3', 'E2F5']",0.9999950664293745,0,0,3
415,Cancer immunotherapy by PD-1 blockade WP4585,0.9571593940867622,0.30628722700198546,0.01341089202698225,['HLA-DRB1'],0.9999950664293745,0,0,1
416,Glycosaminoglycan degradation WP4815,0.9571593940867622,0.30628722700198546,0.01341089202698225,['GNS'],0.9999950664293745,0,0,1
417,MAPK pathway in congenital thyroid cancer WP4928,0.9571593940867622,0.30628722700198546,0.01341089202698225,['ALK'],0.9999950664293745,0,0,1
418,Serotonin and anxiety WP3947,0.9571593940867622,0.30628722700198546,0.01341089202698225,['CRH'],0.9999950664293745,0,0,1
419,SREBF and miR33 in cholesterol and lipid homeostasis WP2011,0.9571593940867622,0.30628722700198546,0.01341089202698225,['SIRT6'],0.9999950664293745,0,0,1
420,Complement system WP2806,0.95797312766473,0.5735903814262023,0.024627419567577385,"['FKBP2', 'RPS19', 'APOA1', 'CD59', 'TXN', 'CALR', 'PRKACA', 'ELANE']",0.9999950664293745,0,0,8
421,Allograft Rejection WP2328,0.9582873624091587,0.5100508062734703,0.021732033199613525,"['CASP9', 'GNLY', 'STAT1', 'BHMT2', 'HLA-DRB1']",0.9999950664293745,0,0,5
422,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.9589667115963049,0.5538678770694229,0.02320646381127467,"['INF2', 'YWHAQ', 'NPHS1', 'CTSL', 'PODXL', 'KRT8', 'FAT1']",0.9999950664293745,0,0,7
423,FGFR3 signaling in chondrocyte proliferation and terminal differentiation WP4767,0.9602036835944675,0.38273750413770274,0.015542911336575913,"['THRA', 'STAT1']",0.9999950664293745,0,0,2
424,Toll-like Receptor Signaling related to MyD88 WP3858,0.9602036835944675,0.38273750413770274,0.015542911336575913,"['TRAF6', 'IKBKG']",0.9999950664293745,0,0,2
425,White fat cell differentiation WP4149,0.9602036835944675,0.38273750413770274,0.015542911336575913,"['WNT10B', 'DDIT3']",0.9999950664293745,0,0,2
426,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.962130787080845,0.4708640150839555,0.018177650800160507,"['BECN1', 'MAP1LC3A', 'WIPI2', 'PLA2G6']",0.9999950664293745,0,0,4
427,BMP Signaling Pathway in Eyelid Development WP3927,0.9648194622950304,0.2871235936465917,0.010283125021662828,['TGFA'],0.9999950664293745,0,0,1
428,GDNF/RET signaling axis WP4830,0.9648194622950304,0.2871235936465917,0.010283125021662828,['IFT27'],0.9999950664293745,0,0,1
429,"GPCRs, Class B Secretin-like WP334",0.9648194622950304,0.2871235936465917,0.010283125021662828,['ADGRE5'],0.9999950664293745,0,0,1
430,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.9648194622950304,0.2871235936465917,0.010283125021662828,['CPT2'],0.9999950664293745,0,0,1
431,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.9648194622950304,0.2871235936465917,0.010283125021662828,['TNC'],0.9999950664293745,0,0,1
432,Monoamine GPCRs WP58,0.9662533072836298,0.36740152267461107,0.012612621030706716,"['ADRA1D', 'HTR5A']",0.9999950664293745,0,0,2
433,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9669127709022962,0.4590592911560119,0.015445964980950942,"['IDI1', 'NSDHL', 'PMVK', 'TM7SF2']",0.9999950664293745,0,0,4
434,Cardiac Hypertrophic Response WP2795,0.9675411626315648,0.48827601765294754,0.01611179493822856,"['CDK7', 'NPPA', 'RAC1', 'IKBKG', 'CALM2']",0.9999950664293745,0,0,5
435,Osteoblast differentiation WP4787,0.9682087907139317,0.604727719971825,0.019537254163946485,"['PRKCG', 'DLL4', 'WNT10B', 'WNT10A', 'HEY1', 'FZD4', 'STAT1', 'NOTCH4', 'PRKCD', 'FGF1', 'DLL1', 'DLL3']",0.9999950664293745,0,0,12
436,Integrated breast cancer pathway WP1984,0.9684961046349769,0.654765866413121,0.020959591115336004,"['UBE2F', 'GADD45A', 'STAT1', 'DCAKD', 'ODC1', 'PHB', 'JAKMIP1', 'CCNB1IP1', 'CASP9', 'CDC42', 'CDK7', 'PAK1', 'RRAS', 'E2F1', 'RHO', 'BAX', 'RAC1', 'FAU']",0.9999950664293745,0,0,18
437,p53 transcriptional gene network WP4963,0.9689469144582707,0.5098884101204287,0.016084660587517587,"['SIVA1', 'XRCC5', 'GADD45A', 'SESN2', 'BAX', 'ISG15']",0.9999950664293745,0,0,6
438,15q13.3 copy number variation syndrome WP4942,0.9711101780725677,0.27021450539183245,0.0079214323856094,['SERPINH1'],0.9999950664293745,0,0,1
439,IL1 and megakaryocytes in obesity WP2865,0.9711101780725677,0.27021450539183245,0.0079214323856094,['IL1R1'],0.9999950664293745,0,0,1
440,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.9711101780725677,0.27021450539183245,0.0079214323856094,['TRAF6'],0.9999950664293745,0,0,1
441,22q11.2 copy number variation syndrome WP4657,0.9711281962939662,0.5865800364433738,0.01718491471850562,"['CDC42', 'RANBP1', 'CYP26B1', 'MRPL40', 'HIRIP3', 'EMC10', 'HIST1H4C', 'SNAP29', 'HIST1H4E', 'RAN', 'RBX1']",0.9999950664293745,0,0,11
442,Ebola Virus Pathway on Host WP4217,0.971190785709772,0.6082208963319548,0.017779723839906707,"['STAT1', 'VPS33A', 'CLTA', 'EIF2S1', 'RHOA', 'ACTG1', 'RHOB', 'CDC42', 'PAK1', 'CTSL', 'RAC1', 'RAB5A', 'HLA-DRB1']",0.9999950664293745,0,0,13
443,PDGFR-beta pathway WP3972,0.9714122616938207,0.35324523209329567,0.01024564002749014,"['STAT1', 'HRAS']",0.9999950664293745,0,0,2
444,Vitamin D Receptor Pathway WP2877,0.9714339407859404,0.6171549454201498,0.01788639055833654,"['CDKN2D', 'G6PD', 'COL13A1', 'GADD45A', 'TPM1', 'RASGRP1', 'STS', 'CYP24A1', 'ADGRE5', 'CREG2', 'S100A6', 'CLPTM1L', 'HLA-DRB1', 'CD200']",0.9999950664293745,0,0,14
445,Glucocorticoid Receptor Pathway WP2880,0.9724696756145046,0.5005815530177479,0.013974427789993164,"['IL11', 'HSP90AA1', 'GPR153', 'PTGES3', 'PDE4B', 'SERPINB9']",0.9999950664293745,0,0,6
446,Wnt signaling pathway and pluripotency WP399,0.9741565957036148,0.5661884918439847,0.014824633532605488,"['PRKCG', 'WNT10B', 'PPP2CB', 'WNT10A', 'CCND2', 'NFYA', 'FZD4', 'PRKCD', 'RHOA', 'PAFAH1B1']",0.9999950664293745,0,0,10
447,Endometrial cancer WP4155,0.9756203451112037,0.4916070836687343,0.012133727517702047,"['CASP9', 'GADD45A', 'ERBB2', 'BAX', 'FGF1', 'HRAS']",0.9999950664293745,0,0,6
448,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.9758055854402284,0.34013755562911474,0.008330617603050773,"['CASP9', 'BAX']",0.9999950664293745,0,0,2
449,Hematopoietic Stem Cell Differentiation WP2849,0.9760766209121865,0.39349101229895933,0.009528066378050695,"['MYB', 'ZNF835', 'VAV1']",0.9999950664293745,0,0,3
450,Lung fibrosis WP3624,0.9760766209121865,0.39349101229895933,0.009528066378050695,"['TERT', 'TGFA', 'FGF1']",0.9999950664293745,0,0,3
451,STING pathway in Kawasaki-like disease and COVID-19 WP4961,0.9762762658192755,0.25518420472093534,0.006126889407516575,['IKBKG'],0.9999950664293745,0,0,1
452,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9767797106232241,0.5097259062776304,0.011975565519615565,"['CASP9', 'GADD45A', 'RAC2', 'CYCS', 'BAX', 'RAC1', 'RHOA']",0.9999950664293745,0,0,7
453,Genes controlling nephrogenesis WP4823,0.9795420834542051,0.32796614176951816,0.006779085830041935,"['NPHS1', 'ETV4']",0.9999950664293745,0,0,2
454,Prion disease pathway WP3995,0.9795420834542051,0.32796614176951816,0.006779085830041935,"['PDIA3', 'HSP90B1']",0.9999950664293745,0,0,2
455,Sleep regulation WP3591,0.9795420834542051,0.32796614176951816,0.006779085830041935,"['STAR', 'CRH']",0.9999950664293745,0,0,2
456,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.9805187260611891,0.2417360409627643,0.00475580247389033,['CYP24A1'],0.9999950664293745,0,0,1
457,"Relationship between inflammation, COX-2 and EGFR WP4483",0.9805187260611891,0.2417360409627643,0.00475580247389033,['HRAS'],0.9999950664293745,0,0,1
458,Vitamin D in inflammatory diseases WP4482,0.9805187260611891,0.2417360409627643,0.00475580247389033,['IKBKG'],0.9999950664293745,0,0,1
459,Kit receptor signaling pathway WP304,0.9806234534475283,0.4498499200873192,0.008802093098747809,"['STAT1', 'INPP5D', 'MAPT', 'HRAS', 'VAV1']",0.9999950664293745,0,0,5
460,Rett syndrome causing genes WP4312,0.9809465898183786,0.41720617904784846,0.008025906046482772,"['SYNGAP1', 'EIF2B2', 'STXBP1', 'RHOBTB2']",0.9999950664293745,0,0,4
461,Toll-like Receptor Signaling Pathway WP75,0.9816479694113797,0.4939706182411753,0.009149579759705097,"['STAT1', 'TRAF6', 'LY96', 'RAC1', 'IKBKG', 'IFNAR1', 'NFKBIB']",0.9999950664293745,0,0,7
462,Neovascularisation processes WP4331,0.982716134254178,0.31663413576230753,0.005520508386158399,"['DLL4', 'NOTCH4']",0.9999950664293745,0,0,2
463,Regulation of Actin Cytoskeleton WP51,0.9836302522449586,0.6008711912640996,0.009917506672300467,"['BRK1', 'ARPC5', 'FGF1', 'RHOA', 'VAV1', 'ACTG1', 'CDC42', 'PAK1', 'MRAS', 'RRAS', 'ABI2', 'TMSB4X', 'CFL1', 'RAC2', 'RAC1', 'FGF22']",0.9999950664293745,0,0,16
464,Fragile X Syndrome  WP4549,0.983699610751904,0.5728820598006644,0.009415146026476801,"['CAMK2A', 'AGAP2', 'CLTA', 'AKAP5', 'TTI1', 'EEF1A1', 'SYNGAP1', 'ALDH5A1', 'PRKAR1A', 'AP2S1', 'PRKACA', 'PTPN5', 'AP2M1']",0.9999950664293745,0,0,13
465,Differentiation of white and brown adipocyte WP2895,0.9840026449407251,0.22963269358041033,0.003703216178461433,['CIDEA'],0.9999950664293745,0,0,1
466,Eicosanoid Synthesis WP167,0.9840026449407251,0.22963269358041033,0.003703216178461433,['PLA2G6'],0.9999950664293745,0,0,1
467,Male infertility WP4673,0.9857863240024064,0.5421539647860172,0.007761290635440722,"['PRMT6', 'BHMT', 'CYP26B1', 'UBE2B', 'XRCC4', 'PARP1', 'XRCC5', 'CAT', 'ERCC2', 'MOV10L1', 'PEX10']",0.9999950664293745,0,0,11
468,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.9861544402622363,0.4957196001972121,0.006911473126360361,"['PRKCG', 'MRAS', 'RRAS', 'ERBB2', 'TGFA', 'BAX', 'EIF4E2', 'HRAS']",0.9999950664293745,0,0,8
469,TGF-beta Signaling Pathway WP366,0.9864507461954896,0.5727401129943502,0.007813253379558006,"['TNC', 'RHOA', 'RBX1', 'CDC42', 'KLF6', 'TERT', 'SUMO1', 'TRAF6', 'CDK1', 'SNIP1', 'STRAP', 'RAC1', 'E2F5', 'SKP1']",0.9999950664293745,0,0,14
470,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.9868636097175169,0.21868204594875673,0.0028917279967529065,['PLA2G6'],0.9999950664293745,0,0,1
471,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.9868636097175169,0.21868204594875673,0.0028917279967529065,['FPR2'],0.9999950664293745,0,0,1
472,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.9868636097175169,0.21868204594875673,0.0028917279967529065,['ABCC4'],0.9999950664293745,0,0,1
473,BDNF-TrkB Signaling WP3676,0.9876922196817839,0.29616341523315287,0.0036677316573412873,"['ADCY1', 'HRAS']",0.9999950664293745,0,0,2
474,MAPK Cascade WP422,0.9876922196817839,0.29616341523315287,0.0036677316573412873,"['RRAS', 'HRAS']",0.9999950664293745,0,0,2
475,Nuclear receptors WP170,0.9876922196817839,0.29616341523315287,0.0036677316573412873,"['RXRB', 'THRA']",0.9999950664293745,0,0,2
476,Interleukin-11 Signaling Pathway WP2332,0.988857747317475,0.34418046357615895,0.0038564707012592138,"['IL11', 'STAT1', 'HRAS']",0.9999950664293745,0,0,3
477,EPO Receptor Signaling WP581,0.9892129784759476,0.20872691173816257,0.0022637734462469285,['STAT1'],0.9999950664293745,0,0,1
478,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.9892129784759476,0.20872691173816257,0.0022637734462469285,['PRKACA'],0.9999950664293745,0,0,1
479,Signaling of Hepatocyte Growth Factor Receptor WP313,0.989625299694392,0.2868876199933797,0.0029919201927489057,"['PAK1', 'HRAS']",0.9999950664293745,0,0,2
480,Wnt signaling WP428,0.9900959948403382,0.5092377475384445,0.005068634809812801,"['PRKCG', 'WNT10B', 'PORCN', 'WNT10A', 'CCND2', 'CSNK2A1', 'CAMK2A', 'RAC1', 'NOTUM', 'RHOA']",0.9999950664293745,0,0,10
481,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9911157591282261,0.4299076068942658,0.003836470141701075,"['WNT10B', 'PORCN', 'WNT10A', 'CCND2', 'CSNK2A1', 'NOTUM']",0.9999950664293745,0,0,6
482,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.9911422085379685,0.1996374413719679,0.001776225205263212,['ASCL1'],0.9999950664293745,0,0,1
483,Signal Transduction of S1P Receptor WP26,0.9911422085379685,0.1996374413719679,0.001776225205263212,['ASAH1'],0.9999950664293745,0,0,1
484,Pathways Regulating Hippo Signaling WP4540,0.9913555185528752,0.4701620104605179,0.004081975587663599,"['PRKCG', 'CDC42', 'PRKAR1A', 'PRKCD', 'PRKAG1', 'RAC1', 'PRKACA', 'RHOA']",0.9999950664293745,0,0,8
485,Energy Metabolism WP1541,0.9918446129615113,0.32774361400189217,0.002683834813606393,"['MYBBP1A', 'PRKAG1', 'MEF2D']",0.9999950664293745,0,0,3
486,Head and Neck Squamous Cell Carcinoma WP4674,0.9922021528415752,0.42326304785701535,0.0033134764021128748,"['TERT', 'SESN2', 'ERBB2', 'E2F1', 'FAT1', 'HRAS']",0.9999950664293745,0,0,6
487,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.9926429813043828,0.2699729345561462,0.0019935382007866165,"['MAP1LC3A', 'EIF2B2']",0.9999950664293745,0,0,2
488,PI3K-Akt signaling pathway WP4172,0.9933579204582668,0.655720765168487,0.004369878137657351,"['HSP90AB1', 'LAMA1', 'TNC', 'TGFA', 'FGF1', 'HSP90B1', 'CASP9', 'PPP2CB', 'GNG10', 'GNG3', 'CCND2', 'CREB3L4', 'CREB3L1', 'MYB', 'CREB3L2', 'RAC1', 'IKBKG', 'HRAS', 'JAK3', 'FGF22', 'EIF4B', 'HSP90AA1', 'PPP2R5A', 'EFNA2', 'CDC37', 'GNB1', 'COL9A3', 'GNB5', 'EIF4E2', 'PIK3AP1', 'SGK2', 'ATF4', 'IFNAR1', 'CREB5']",0.9999950664293745,0,0,34
489,Hedgehog Signaling Pathway WP4249,0.9938104080901403,0.2622405069276966,0.0016282058994889145,"['CCND2', 'PRKACA']",0.9999950664293745,0,0,2
490,IL-5 signaling pathway WP127,0.9938104080901403,0.2622405069276966,0.0016282058994889145,"['STAT1', 'MAPT']",0.9999950664293745,0,0,2
491,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.9940500442435671,0.3128010234798314,0.0018667111983425512,"['IL1R1', 'TRAF6', 'NFKBIB']",0.9999950664293745,0,0,3
492,Gastrin signaling pathway WP4659,0.9943544492491087,0.4822610791831886,0.002730343817394924,"['CDC42', 'PAK1', 'CCKBR', 'PRKCD', 'RAC1', 'PRKACA', 'HRAS', 'MEF2D', 'RHOA', 'RHOB']",0.9999950664293745,0,0,10
493,Vitamin B12 metabolism WP1533,0.9947955851666979,0.2549376586119387,0.0013302659704857722,"['APOA1', 'SOD1']",0.9999950664293745,0,0,2
494,IL-4 signaling pathway WP395,0.9949235800446993,0.30582781456953645,0.0015564644052739446,"['STAT1', 'INPP5D', 'JAK3']",0.9999950664293745,0,0,3
495,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.9949235800446993,0.30582781456953645,0.0015564644052739446,"['SYNGAP1', 'PRKAG1', 'HRAS']",0.9999950664293745,0,0,3
496,Ethanol effects on histone modifications WP3996,0.9950954627744137,0.17656417044239678,0.0008680960958625792,['EHMT2'],0.9999950664293745,0,0,1
497,Nanoparticle-mediated activation of receptor signaling WP2643,0.9950954627744137,0.17656417044239678,0.0008680960958625792,['HRAS'],0.9999950664293745,0,0,1
498,Resistin as a regulator of inflammation WP4481,0.9950954627744137,0.17656417044239678,0.0008680960958625792,['IKBKG'],0.9999950664293745,0,0,1
499,Pathways in clear cell renal cell carcinoma WP4018,0.9952937632865747,0.42213894318023176,0.0019913754188147135,"['TPI1', 'EFCAB3', 'PGK1', 'VHL', 'ALDOA', 'SQSTM1', 'PFKM']",0.9999950664293745,0,0,7
500,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9955061040056867,0.521103356596876,0.002347061971860908,"['WNT10B', 'WNT10A', 'FZD4', 'PDCD6', 'NOTCH4', 'DLL1', 'DLL3', 'DLL4', 'PAK1', 'RBBP4', 'TRAF6', 'STRAP', 'HRAS', 'MEF2D']",0.9999950664293745,0,0,14
501,Circadian rhythm related genes WP3594,0.9958799465709977,0.5608350156780207,0.002315443386803326,"['PRKCG', 'PRMT5', 'SUV39H1', 'CAVIN3', 'ADCY1', 'CARTPT', 'ATOH7', 'AANAT', 'STAR', 'MYBBP1A', 'THRAP3', 'NOCT', 'CRY2', 'CRH', 'ATF5', 'RPS27A', 'UBA52', 'SKP1', 'ATF4']",0.9999950664293745,0,0,19
502,Glycerophospholipid Biosynthetic Pathway WP2533,0.9959725765365165,0.17001250091918524,0.0006860948618115524,['CDIPT'],0.9999950664293745,0,0,1
503,Adipogenesis WP236,0.9960067853769133,0.4673963843751905,0.0018701505231287475,"['WNT10B', 'CYP26B1', 'KLF6', 'GADD45A', 'STAT1', 'DDIT3', 'CISD1', 'E2F1', 'LPL', 'MEF2D']",0.9999950664293745,0,0,10
504,Oncostatin M Signaling Pathway WP2374,0.9961504507997644,0.33349995483152156,0.0012863019172023387,"['STAT1', 'PRKCD', 'JAK3', 'HRAS']",0.9999950664293745,0,0,4
505,Wnt Signaling Pathway WP363,0.9963125248179648,0.2927715936311117,0.0010815833692670006,"['PRKCG', 'RAC1', 'RHOA']",0.9999950664293745,0,0,3
506,Integrin-mediated Cell Adhesion WP185,0.9963277074035316,0.4312242708028485,0.0015864965230083714,"['CDC42', 'PAK1', 'CAPNS1', 'RAC2', 'RHO', 'ITGAE', 'RAC1', 'HRAS']",0.9999950664293745,0,0,8
507,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9964960103982584,0.3873262778527312,0.0013595706042106698,"['CDK7', 'NPPA', 'RAC1', 'IKBKG', 'CALM2', 'RHOA']",0.9999950664293745,0,0,6
508,Heart Development WP1591,0.9966927857895665,0.1639288077904888,0.0005430461634100564,['HEY1'],0.9999950664293745,0,0,1
509,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.9966927857895665,0.1639288077904888,0.0005430461634100564,['HRAS'],0.9999950664293745,0,0,1
510,Splicing factor NOVA regulated synaptic proteins WP4148,0.9969159093945124,0.23527614391566726,0.0007267341790975343,"['NTNG1', 'CLSTN1']",0.9999950664293745,0,0,2
511,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9969416240711423,0.3819191249585681,0.0011698420802292461,"['WNT10B', 'PORCN', 'WNT10A', 'CCND2', 'CSNK2A1', 'NOTUM']",0.9999950664293745,0,0,6
512,Regulation of toll-like receptor signaling pathway WP1449,0.9971464136559628,0.4385385929492157,0.0012531966441975029,"['OTUD5', 'STAT1', 'TRAF6', 'TRAFD1', 'LY96', 'RAC1', 'IKBKG', 'SQSTM1', 'IFNAR1']",0.9999950664293745,0,0,9
513,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9974124428563996,0.6064149682592717,0.001571167003082252,"['HSP90AB1', 'LAMA1', 'TNC', 'ITGAE', 'FGF1', 'HSP90B1', 'CASP9', 'PPP2CB', 'GNG10', 'GNG3', 'CREB3L4', 'CREB3L1', 'CREB3L2', 'IKBKG', 'HRAS', 'JAK3', 'RAB8A', 'FGF22', 'EIF4B', 'RAB2A', 'HSP90AA1', 'PPP2R5A', 'EFNA2', 'RAB14', 'CDC37', 'GNB1', 'EIF4E2', 'ATF4', 'IFNAR1', 'CREB5']",0.9999950664293745,0,0,30
514,The influence of laminopathies on Wnt signaling WP4844,0.9977697130240889,0.1529781601588352,0.0003415662353065381,['WNT10B'],0.9999950664293745,0,0,1
515,TGF-beta Receptor Signaling WP560,0.9978292718829205,0.2237669645812645,0.00048626520761947694,"['STAT1', 'HRAS']",0.9999950664293745,0,0,2
516,Pathways affected in adenoid cystic carcinoma WP3651,0.9978985046590796,0.3107999618237041,0.0006538319249815265,"['MYB', 'ERBB2', 'DTX4', 'HRAS']",0.9999950664293745,0,0,4
517,Glioblastoma signaling pathways WP2261,0.9979748912992401,0.3665628107391449,0.0007430822027297621,"['PRKCG', 'CCND2', 'PRKCD', 'ERBB2', 'E2F1', 'HRAS']",0.9999950664293745,0,0,6
518,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.9981683970309875,0.14803270638970134,0.00027138575595179304,['SUPT4H1'],0.9999950664293745,0,0,1
519,Focal Adhesion WP306,0.9982782331427921,0.5297103861517976,0.0009128238474168872,"['PRKCG', 'LAMA1', 'TNC', 'TESK2', 'PARVB', 'RHOA', 'VAV1', 'MYL12B', 'ACTG1', 'CDC42', 'MYL5', 'PAK1', 'MYL7', 'CCND2', 'ERBB2', 'RAC2', 'RAC1', 'HRAS', 'PPP1R12C']",0.9999950664293745,0,0,19
520,Insulin Signaling WP481,0.998534632923467,0.49008596124620063,0.0007186825278351953,"['CAP1', 'XBP1', 'ARF1', 'RRAD', 'STXBP1', 'PRKCD', 'PPP1R3A', 'PTPRF', 'EHD2', 'RAC2', 'RAC1', 'HRAS', 'SGK2', 'PFKM', 'VAMP2']",0.9999950664293745,0,0,15
521,MECP2 and Associated Rett Syndrome WP3584,0.9986741853331514,0.29569714389511587,0.00039229972618975615,"['PRPF38A', 'CAMK2A', 'E2F1', 'NREP']",0.9999950664293745,0,0,4
522,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9986741853331514,0.29569714389511587,0.00039229972618975615,"['IFNGR2', 'STMN1', 'JAK3', 'IFNAR1']",0.9999950664293745,0,0,4
523,TYROBP causal network in microglia WP3945,0.9987220318083186,0.2084649875116608,0.00026658200108315566,"['ABCC4', 'CREB3L2']",0.9999950664293745,0,0,2
524,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.9989296489833461,0.203817720401633,0.00021827333963937904,"['STAT1', 'HRAS']",0.9999950664293745,0,0,2
525,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.9989851761500592,0.13494179935375872,0.00013701168946784122,['DDIT3'],0.9999950664293745,0,0,1
526,Mesodermal commitment pathway WP2857,0.9990581286921192,0.41604562049301513,0.00039204609019006853,"['WDHD1', 'ARL4A', 'WDCP', 'PRKAR1A', 'FZD4', 'NABP2', 'RPL38', 'HPRT1', 'PRKACA', 'DLL1']",0.9999950664293745,0,0,10
527,ErbB signaling pathway WP673,0.9991271017221632,0.3392626965712813,0.0002962711496797255,"['PRKCG', 'PAK1', 'CAMK2A', 'ERBB2', 'TGFA', 'HRAS']",0.9999950664293745,0,0,6
528,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.9991663490795731,0.13107686489552803,0.0001093179218936595,['RHOA'],0.9999950664293745,0,0,1
529,Development of ureteric collection system WP5053,0.999315093344852,0.12742664901831016,8.73052613471656e-05,['ETV4'],0.9999950664293745,0,0,1
530,AMP-activated protein kinase (AMPK) signaling WP1403,0.99948324399245,0.23302278594679537,0.00012044704808288963,"['PRKAG1', 'SLC2A4RG', 'CAMKK2']",0.9999950664293745,0,0,3
531,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.999537466947435,0.12070256713922463,5.5841842175987296e-05,['STAT1'],0.9999950664293745,0,0,1
532,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.9995604951361586,0.18336974511751075,8.060961031626252e-05,"['WNT10B', 'E2F1']",0.9999950664293745,0,0,2
533,Endoderm differentiation WP2853,0.9995729980512799,0.37777831891539787,0.00016134652845418667,"['WDHD1', 'STAT1', 'SIAH2', 'TCEAL2', 'CTR9', 'NABP2', 'HPRT1', 'RTF1', 'NME1']",0.9999950664293745,0,0,9
534,ESC Pluripotency Pathways WP3931,0.9995800336952463,0.3408593882273266,0.00014317952510732384,"['WNT10B', 'ACTR2', 'WNT10A', 'FZD4', 'FGF1', 'HRAS', 'FGF22']",0.9999950664293745,0,0,7
535,Ectoderm Differentiation WP2858,0.9996088712250388,0.39095543244232256,0.00015294383167252198,"['ABCC4', 'ARHGEF9', 'TSC22D1', 'PODXL', 'FZD4', 'HMGB2', 'JAKMIP1', 'VAX2', 'LY6E', 'CAP2']",0.9999950664293745,0,0,10
536,Hippo-Merlin Signaling Dysregulation WP4541,0.9996821549013909,0.3337097977453581,0.00010608488374461346,"['DDB1', 'PAK1', 'PRKAR1A', 'ITGAE', 'PRKACA', 'HRAS', 'RBX1']",0.9999950664293745,0,0,7
537,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.9997754883683276,0.21474027317880795,4.821710196981877e-05,"['DSG2', 'ACTG1', 'CACNG5']",0.9999950664293745,0,0,3
538,Complement and Coagulation Cascades WP558,0.9998257166419493,0.10662890739230142,1.8585263643733746e-05,['F8'],0.9999950664293745,0,0,1
539,"GPCRs, Class A Rhodopsin-like WP455",0.999899471584745,0.3428749170537492,3.4470404698708024e-05,"['MAS1', 'CCKBR', 'NPY5R', 'GPR22', 'RHO', 'ADRA1D', 'FPR2', 'SSTR1', 'HTR5A']",0.9999950664293745,0,0,9
540,Phosphoinositides metabolism WP4971,0.9999192103364459,0.09752594449216385,7.879406534902254e-06,['INPP5D'],0.9999950664293745,0,0,1
541,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.9999950664293745,0.19515386314591085,9.628077417067896e-07,"['CAP1', 'THRA', 'PRKAG1', 'LPL', 'HRAS']",0.9999950664293745,0,0,5
